<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"크리스탈지노믹스" - Google 뉴스</title><link>https://news.google.com/search?pz=1&amp;cf=all&amp;hl=ko&amp;q=%ED%81%AC%EB%A6%AC%EC%8A%A4%ED%83%88%EC%A7%80%EB%85%B8%EB%AF%B9%EC%8A%A4&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Mon, 18 May 2026 10:20:41 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>'아이발티노스타트' 비임상 연구 'Hypertension' 실려 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9sUlNtWmR5MGsxcjJ3Z1phQkVPcExoQXQtN1VxNmxCbDkwakRKOFpROTNEdmdlUmpnOURYbDRDNG9BMEFSOHJCYXd4WW1kU3lDdFR4V1E2SDFhOGxSQjdvbEdFWDFWcjl0YUdBb0dB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9sUlNtWmR5MGsxcjJ3Z1phQkVPcExoQXQtN1VxNmxCbDkwakRKOFpROTNEdmdlUmpnOURYbDRDNG9BMEFSOHJCYXd4WW1kU3lDdFR4V1E2SDFhOGxSQjdvbEdFWDFWcjl0YUdBb0dB</guid><pubDate>Sat, 16 May 2026 23:01:22 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9sUlNtWmR5MGsxcjJ3Z1phQkVPcExoQXQtN1VxNmxCbDkwakRKOFpROTNEdmdlUmpnOURYbDRDNG9BMEFSOHJCYXd4WW1kU3lDdFR4V1E2SDFhOGxSQjdvbEdFWDFWcjl0YUdBb0dB?oc=5" target="_blank"&gt;'아이발티노스타트' 비임상 연구 'Hypertension' 실려&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈지노믹스, 대웅제약과 신약 '아셀렉스' 판권계약 - 약업신문</title><link>https://news.google.com/rss/articles/CBMivgFBVV95cUxNeXNfMUNzRWJKbUlQdXZYTXZjYUU2MlVaYXhBenRHUE5vYXhZV29OMC0yQVQ5VklCNmFKcnZ0a21QcmhNUXJ0SkZwckJ4VkhGX0ItRjR2RXRlS2poYUJnWm5iNlZXQ1J6WDdiV0lZQl9mVWEzckpycTZLd294dVg5WFpkNFcxQ25QX3JSMXJMYml0Qk52NG1ySHE3MEVkZkxuOVhPMFhlRDZSTmw2SjVXWTh2RFZJekdFTUZyb2h3?oc=5</link><guid isPermaLink="false">CBMivgFBVV95cUxNeXNfMUNzRWJKbUlQdXZYTXZjYUU2MlVaYXhBenRHUE5vYXhZV29OMC0yQVQ5VklCNmFKcnZ0a21QcmhNUXJ0SkZwckJ4VkhGX0ItRjR2RXRlS2poYUJnWm5iNlZXQ1J6WDdiV0lZQl9mVWEzckpycTZLd294dVg5WFpkNFcxQ25QX3JSMXJMYml0Qk52NG1ySHE3MEVkZkxuOVhPMFhlRDZSTmw2SjVXWTh2RFZJekdFTUZyb2h3</guid><pubDate>Thu, 14 May 2026 17:00:04 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNeXNfMUNzRWJKbUlQdXZYTXZjYUU2MlVaYXhBenRHUE5vYXhZV29OMC0yQVQ5VklCNmFKcnZ0a21QcmhNUXJ0SkZwckJ4VkhGX0ItRjR2RXRlS2poYUJnWm5iNlZXQ1J6WDdiV0lZQl9mVWEzckpycTZLd294dVg5WFpkNFcxQ25QX3JSMXJMYml0Qk52NG1ySHE3MEVkZkxuOVhPMFhlRDZSTmw2SjVXWTh2RFZJekdFTUZyb2h3?oc=5" target="_blank"&gt;크리스탈지노믹스, 대웅제약과 신약 '아셀렉스' 판권계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>크리스탈지노믹스, 파미노젠과 의료용 대마 신약 개발 나서 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE41bnAxS3lHV2FRTWZEci15TWlTc0djMlJoelFFc2dtalZORktLLVFrMTN3TE14OEtHdklfelAwUWZjV240UlRRLUMwcWR3eXFwUzBOQ19jeTlXRGRNV1Y5Zk5BckRXb2dyemxMSVJB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE41bnAxS3lHV2FRTWZEci15TWlTc0djMlJoelFFc2dtalZORktLLVFrMTN3TE14OEtHdklfelAwUWZjV240UlRRLUMwcWR3eXFwUzBOQ19jeTlXRGRNV1Y5Zk5BckRXb2dyemxMSVJB</guid><pubDate>Sat, 16 May 2026 15:36:09 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE41bnAxS3lHV2FRTWZEci15TWlTc0djMlJoelFFc2dtalZORktLLVFrMTN3TE14OEtHdklfelAwUWZjV240UlRRLUMwcWR3eXFwUzBOQ19jeTlXRGRNV1Y5Zk5BckRXb2dyemxMSVJB?oc=5" target="_blank"&gt;크리스탈지노믹스, 파미노젠과 의료용 대마 신약 개발 나서&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈, 화일 지분 절반 엑시트…사실상 300억 성과 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1TUk1Ed1JqNGhSQk5MNjlzNDQ2MVVrRUJoVVU3UTVNWEJ6a3lCNFlqOEJrYXZCcDNGMXRSeXMxbDZIMnJpY0RYV3A2YWp0ajg?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1TUk1Ed1JqNGhSQk5MNjlzNDQ2MVVrRUJoVVU3UTVNWEJ6a3lCNFlqOEJrYXZCcDNGMXRSeXMxbDZIMnJpY0RYV3A2YWp0ajg</guid><pubDate>Sat, 14 Mar 2026 16:50:03 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1TUk1Ed1JqNGhSQk5MNjlzNDQ2MVVrRUJoVVU3UTVNWEJ6a3lCNFlqOEJrYXZCcDNGMXRSeXMxbDZIMnJpY0RYV3A2YWp0ajg?oc=5" target="_blank"&gt;크리스탈, 화일 지분 절반 엑시트…사실상 300억 성과&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>[단독] 크리스탈지노믹스, 최대주주 이름딴 ‘CG인바이츠’로 사명변경 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxPN19kdW91WmZkbldqZmhQSXRhRnVoQjZqUkdVY1FoeEtHYVU2aTZoWkdhX0pZTWVleno3eDB5VDkyd2szZWpMUkROdTI4aHI4LTRTOGh4Y1ZFbk9Wc1NfY2NlMk1GQ2RLWVhFR1Y3eld1MzBFeE1rTjdSOFRiVnhfWUE2Zw?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxPN19kdW91WmZkbldqZmhQSXRhRnVoQjZqUkdVY1FoeEtHYVU2aTZoWkdhX0pZTWVleno3eDB5VDkyd2szZWpMUkROdTI4aHI4LTRTOGh4Y1ZFbk9Wc1NfY2NlMk1GQ2RLWVhFR1Y3eld1MzBFeE1rTjdSOFRiVnhfWUE2Zw</guid><pubDate>Thu, 29 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPN19kdW91WmZkbldqZmhQSXRhRnVoQjZqUkdVY1FoeEtHYVU2aTZoWkdhX0pZTWVleno3eDB5VDkyd2szZWpMUkROdTI4aHI4LTRTOGh4Y1ZFbk9Wc1NfY2NlMk1GQ2RLWVhFR1Y3eld1MzBFeE1rTjdSOFRiVnhfWUE2Zw?oc=5" target="_blank"&gt;[단독] 크리스탈지노믹스, 최대주주 이름딴 ‘CG인바이츠’로 사명변경&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스, 혈액암 치료물질 임상 1상 성공 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE8ydWktVnVSYm10YWU5eTZFdVN4ZXNCcDh6WDhYZjJuSDd0b25ZTnc3eE8yeGNrc0QxNFVXWTFULS1FWGFCYnIyRnpwN0RWNGxPNE1wN3FWbG9kMTRkVGJSZ2x5RXdWM1ZwQmFhcWhn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE8ydWktVnVSYm10YWU5eTZFdVN4ZXNCcDh6WDhYZjJuSDd0b25ZTnc3eE8yeGNrc0QxNFVXWTFULS1FWGFCYnIyRnpwN0RWNGxPNE1wN3FWbG9kMTRkVGJSZ2x5RXdWM1ZwQmFhcWhn</guid><pubDate>Sat, 16 May 2026 20:18:52 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE8ydWktVnVSYm10YWU5eTZFdVN4ZXNCcDh6WDhYZjJuSDd0b25ZTnc3eE8yeGNrc0QxNFVXWTFULS1FWGFCYnIyRnpwN0RWNGxPNE1wN3FWbG9kMTRkVGJSZ2x5RXdWM1ZwQmFhcWhn?oc=5" target="_blank"&gt;크리스탈지노믹스, 혈액암 치료물질 임상 1상 성공&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://medicaltimes.com">메디칼타임즈</source></item><item><title>조중명 회장, CG인바이츠 경영 일선에서 물러나기로 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE41LXgyU0FfeG1IYm1UcXVUajM5X3JNYkRlM2I1azhSSE4xWFllSTRQaVRVTlhEMHZsVTlZOFA4dXJRQUN6c3dLMzB6MnVBNXQ2a3A5QVB5QmI5OHhMWFp4X3oyU2x2WWRYZ1BB?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE41LXgyU0FfeG1IYm1UcXVUajM5X3JNYkRlM2I1azhSSE4xWFllSTRQaVRVTlhEMHZsVTlZOFA4dXJRQUN6c3dLMzB6MnVBNXQ2a3A5QVB5QmI5OHhMWFp4X3oyU2x2WWRYZ1BB</guid><pubDate>Tue, 13 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE41LXgyU0FfeG1IYm1UcXVUajM5X3JNYkRlM2I1azhSSE4xWFllSTRQaVRVTlhEMHZsVTlZOFA4dXJRQUN6c3dLMzB6MnVBNXQ2a3A5QVB5QmI5OHhMWFp4X3oyU2x2WWRYZ1BB?oc=5" target="_blank"&gt;조중명 회장, CG인바이츠 경영 일선에서 물러나기로&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>[CG인바이츠 is] ①조중명 회장 퇴진 후 2년…신용규 체제 '명과 암' - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTE03UlZMeHQ3UlliSHo1ZHctWEs3LWpnalBXY1dsWFVDOVlrdTl6YjVOWmZFTndfM090NmRXWE14MzMtMkxzOEE2M1F5RFlEd3VHZ0U0?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTE03UlZMeHQ3UlliSHo1ZHctWEs3LWpnalBXY1dsWFVDOVlrdTl6YjVOWmZFTndfM090NmRXWE14MzMtMkxzOEE2M1F5RFlEd3VHZ0U0</guid><pubDate>Tue, 05 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE03UlZMeHQ3UlliSHo1ZHctWEs3LWpnalBXY1dsWFVDOVlrdTl6YjVOWmZFTndfM090NmRXWE14MzMtMkxzOEE2M1F5RFlEd3VHZ0U0?oc=5" target="_blank"&gt;[CG인바이츠 is] ①조중명 회장 퇴진 후 2년…신용규 체제 '명과 암'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>같은 듯 다른 헬릭스미스와 크리스탈지노믹스 경영권 매각 - 코메디닷컴</title><link>https://news.google.com/rss/articles/CBMiQkFVX3lxTE9ub1l0NzM2NmVkNy1wX2k1U0xLWmNRREhyRXgyYnk0RXg0UUgtNjB3UUZ3WGhMMHh5TFc1ZWwwaHlqQQ?oc=5</link><guid isPermaLink="false">CBMiQkFVX3lxTE9ub1l0NzM2NmVkNy1wX2k1U0xLWmNRREhyRXgyYnk0RXg0UUgtNjB3UUZ3WGhMMHh5TFc1ZWwwaHlqQQ</guid><pubDate>Wed, 24 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiQkFVX3lxTE9ub1l0NzM2NmVkNy1wX2k1U0xLWmNRREhyRXgyYnk0RXg0UUgtNjB3UUZ3WGhMMHh5TFc1ZWwwaHlqQQ?oc=5" target="_blank"&gt;같은 듯 다른 헬릭스미스와 크리스탈지노믹스 경영권 매각&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;코메디닷컴&lt;/font&gt;</description><source url="https://kormedi.com">코메디닷컴</source></item><item><title>크리스탈지노믹스, 620억 3자배정 유증..최대주주 변경 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE93MTJBbjNuQlB3eU80REJpVURWQ0ZGRVUyNmV0eTQ4czZQcGtGcGVPekVyZmFWVVhVS0RGMUowN09taExRcjZ1VFNIUzN0QkJZMTBGdTlVNA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE93MTJBbjNuQlB3eU80REJpVURWQ0ZGRVUyNmV0eTQ4czZQcGtGcGVPekVyZmFWVVhVS0RGMUowN09taExRcjZ1VFNIUzN0QkJZMTBGdTlVNA</guid><pubDate>Mon, 22 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE93MTJBbjNuQlB3eU80REJpVURWQ0ZGRVUyNmV0eTQ4czZQcGtGcGVPekVyZmFWVVhVS0RGMUowN09taExRcjZ1VFNIUzN0QkJZMTBGdTlVNA?oc=5" target="_blank"&gt;크리스탈지노믹스, 620억 3자배정 유증..최대주주 변경&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>크리스탈지노믹스,상호 ' 씨지인바이츠'로 변경 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFB2M0l3Qk1MVVZTRktlZDBLZUYza0kwR1p3UnE5Zkc3SW82RnJPVGMwdzlJRUd6UUJfVF9LYktkTWNadEJIWWFtdTNHbVZqNzV5R0NOSG9CV21aV290SHBzSkhJaEJkMWFkTHQ4SA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFB2M0l3Qk1MVVZTRktlZDBLZUYza0kwR1p3UnE5Zkc3SW82RnJPVGMwdzlJRUd6UUJfVF9LYktkTWNadEJIWWFtdTNHbVZqNzV5R0NOSG9CV21aV290SHBzSkhJaEJkMWFkTHQ4SA</guid><pubDate>Thu, 29 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB2M0l3Qk1MVVZTRktlZDBLZUYza0kwR1p3UnE5Zkc3SW82RnJPVGMwdzlJRUd6UUJfVF9LYktkTWNadEJIWWFtdTNHbVZqNzV5R0NOSG9CV21aV290SHBzSkhJaEJkMWFkTHQ4SA?oc=5" target="_blank"&gt;크리스탈지노믹스,상호 ' 씨지인바이츠'로 변경&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>[MK시그널] 오늘의 종목 분석 : 박셀바이오, 크리스탈지노믹스 - 매일경제 마켓</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTFAwZXJZX0l3VUpVbTRaTHZfV0V5UFd1d2pVV2wwRVE5ZUtIVHpZbnMwRl9WSk9haWx5V3drc2J5UzNaTDJsUWgxT05ZS3pYNkU?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTFAwZXJZX0l3VUpVbTRaTHZfV0V5UFd1d2pVV2wwRVE5ZUtIVHpZbnMwRl9WSk9haWx5V3drc2J5UzNaTDJsUWgxT05ZS3pYNkU</guid><pubDate>Mon, 13 Mar 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFAwZXJZX0l3VUpVbTRaTHZfV0V5UFd1d2pVV2wwRVE5ZUtIVHpZbnMwRl9WSk9haWx5V3drc2J5UzNaTDJsUWgxT05ZS3pYNkU?oc=5" target="_blank"&gt;[MK시그널] 오늘의 종목 분석 : 박셀바이오, 크리스탈지노믹스&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매일경제 마켓&lt;/font&gt;</description><source url="https://stock.mk.co.kr">매일경제 마켓</source></item><item><title>새 주인 맞는 크리스탈지노믹스… 신약 개발 향방은 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxQT05yYmU1X2VReGpnTlpxejZFWE1vcDY0RjBPUmpMMzluQ3J4akZEbjlBNG5iT1NyeGd6SVlZcHkxaTc2TngyU0ZvR0REVWhzM3BlaDZQVUpKVE9Ndkl1Rmh0OERRREhaT3huTVJWOTR4MlBqZ3d2YnZFdmhRWWJ5cjZ4WQ?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxQT05yYmU1X2VReGpnTlpxejZFWE1vcDY0RjBPUmpMMzluQ3J4akZEbjlBNG5iT1NyeGd6SVlZcHkxaTc2TngyU0ZvR0REVWhzM3BlaDZQVUpKVE9Ndkl1Rmh0OERRREhaT3huTVJWOTR4MlBqZ3d2YnZFdmhRWWJ5cjZ4WQ</guid><pubDate>Thu, 25 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQT05yYmU1X2VReGpnTlpxejZFWE1vcDY0RjBPUmpMMzluQ3J4akZEbjlBNG5iT1NyeGd6SVlZcHkxaTc2TngyU0ZvR0REVWhzM3BlaDZQVUpKVE9Ndkl1Rmh0OERRREhaT3huTVJWOTR4MlBqZ3d2YnZFdmhRWWJ5cjZ4WQ?oc=5" target="_blank"&gt;새 주인 맞는 크리스탈지노믹스… 신약 개발 향방은&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스 '아셀렉스' 뇌졸중 등 부작용 추가 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1kRXdSUUE0TlhGTUUxakZoVU1kQWdJVWN1V1VEVXFob1JoQzYtV2RwUmVsMzRTU25lUG9kREgxS0ZYemp2bHhYNmdta25wd3pRWVJxSXRIMS1veXBILVNzQzd4QkoteHNrX1BNc2hn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1kRXdSUUE0TlhGTUUxakZoVU1kQWdJVWN1V1VEVXFob1JoQzYtV2RwUmVsMzRTU25lUG9kREgxS0ZYemp2bHhYNmdta25wd3pRWVJxSXRIMS1veXBILVNzQzd4QkoteHNrX1BNc2hn</guid><pubDate>Tue, 31 May 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1kRXdSUUE0TlhGTUUxakZoVU1kQWdJVWN1V1VEVXFob1JoQzYtV2RwUmVsMzRTU25lUG9kREgxS0ZYemp2bHhYNmdta25wd3pRWVJxSXRIMS1veXBILVNzQzd4QkoteHNrX1BNc2hn?oc=5" target="_blank"&gt;크리스탈지노믹스 '아셀렉스' 뇌졸중 등 부작용 추가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 화일약품 지분 처분… 13%만 남긴다 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBiSGt4ejk1NjFOT0FIR1hrS0g4b1ZxaWFtaDkyOGdRTzV5ZWY4VEEyTzBmTnZLUDhPSDhSWWU5ek5BNGo4NFo5c3U3ZmlkZjBiYUo5TzA3aUMxSFF1RjFqVnNCeEZ1RS0zdm84?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBiSGt4ejk1NjFOT0FIR1hrS0g4b1ZxaWFtaDkyOGdRTzV5ZWY4VEEyTzBmTnZLUDhPSDhSWWU5ek5BNGo4NFo5c3U3ZmlkZjBiYUo5TzA3aUMxSFF1RjFqVnNCeEZ1RS0zdm84</guid><pubDate>Wed, 13 Jan 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBiSGt4ejk1NjFOT0FIR1hrS0g4b1ZxaWFtaDkyOGdRTzV5ZWY4VEEyTzBmTnZLUDhPSDhSWWU5ek5BNGo4NFo5c3U3ZmlkZjBiYUo5TzA3aUMxSFF1RjFqVnNCeEZ1RS0zdm84?oc=5" target="_blank"&gt;크리스탈지노믹스, 화일약품 지분 처분… 13%만 남긴다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>크리스탈지노믹스, '섬유증 신약' 포커스.."마카온 설립" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE84aWpnblNfNldlYnJ3aTg5OEFhbUNrbnBPLWNaOVAxc2hTS1l4aUpKdW1yUkJjZmxfRTBIUHNZNnFwZkpyTHRSVzBBNWxLb3NxZGZrMmViZw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE84aWpnblNfNldlYnJ3aTg5OEFhbUNrbnBPLWNaOVAxc2hTS1l4aUpKdW1yUkJjZmxfRTBIUHNZNnFwZkpyTHRSVzBBNWxLb3NxZGZrMmViZw</guid><pubDate>Mon, 13 Jul 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE84aWpnblNfNldlYnJ3aTg5OEFhbUNrbnBPLWNaOVAxc2hTS1l4aUpKdW1yUkJjZmxfRTBIUHNZNnFwZkpyTHRSVzBBNWxLb3NxZGZrMmViZw?oc=5" target="_blank"&gt;크리스탈지노믹스, '섬유증 신약' 포커스.."마카온 설립"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>조중명 전 크리스탈지노믹스 대표 복귀 앞두고 ‘시끌’[화제의 바이오人] - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBCM05WNlpQWmVoT24zczNTMEt6U2FjQ1FpUDNvTHZmQ0FzeFowQ29XZTA2LUxfVUxJcHc3OFp5TUMtOUVVU0hCQW11dTlkckh1bTBkemNxSERtQ2Zya1lDVTYyNEh3ZTM2MWVtblZ3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBCM05WNlpQWmVoT24zczNTMEt6U2FjQ1FpUDNvTHZmQ0FzeFowQ29XZTA2LUxfVUxJcHc3OFp5TUMtOUVVU0hCQW11dTlkckh1bTBkemNxSERtQ2Zya1lDVTYyNEh3ZTM2MWVtblZ3</guid><pubDate>Sat, 24 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBCM05WNlpQWmVoT24zczNTMEt6U2FjQ1FpUDNvTHZmQ0FzeFowQ29XZTA2LUxfVUxJcHc3OFp5TUMtOUVVU0hCQW11dTlkckh1bTBkemNxSERtQ2Zya1lDVTYyNEh3ZTM2MWVtblZ3?oc=5" target="_blank"&gt;조중명 전 크리스탈지노믹스 대표 복귀 앞두고 ‘시끌’[화제의 바이오人]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스의 화일약품 '적재적소' 활용법 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTFBwQzBTcnJwVzNwd1RHM2JqLUJjOUxYLUNiMG0zekYwQklSQWZQblJjUGhxMDZBWnIybEZ1ZnE4dnIycDZXMDc3ZW9oWThjdmc?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTFBwQzBTcnJwVzNwd1RHM2JqLUJjOUxYLUNiMG0zekYwQklSQWZQblJjUGhxMDZBWnIybEZ1ZnE4dnIycDZXMDc3ZW9oWThjdmc</guid><pubDate>Thu, 19 Dec 2019 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBwQzBTcnJwVzNwd1RHM2JqLUJjOUxYLUNiMG0zekYwQklSQWZQblJjUGhxMDZBWnIybEZ1ZnE4dnIycDZXMDc3ZW9oWThjdmc?oc=5" target="_blank"&gt;크리스탈지노믹스의 화일약품 '적재적소' 활용법&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>[크리스탈지노믹스, 주주연대 소송전]②“경영권 방어” vs “임상에 필요한 자금” - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxPcVlXSEM4ZTE4SF9XUDZxY05Hazhwb2FDcXJhdkpGQlcxWmZHQldTQ0xVS2xQS0haM1IxR1M5cVViYzFlU3ZGR0w5SXY0Y0ZDQ3E4X3daS25IV2h3VXFBdU5yLTk1VE1xQXZabVNRYlFYTG9EbWVSRUt0RWtVSVhCM1d2OA?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxPcVlXSEM4ZTE4SF9XUDZxY05Hazhwb2FDcXJhdkpGQlcxWmZHQldTQ0xVS2xQS0haM1IxR1M5cVViYzFlU3ZGR0w5SXY0Y0ZDQ3E4X3daS25IV2h3VXFBdU5yLTk1VE1xQXZabVNRYlFYTG9EbWVSRUt0RWtVSVhCM1d2OA</guid><pubDate>Mon, 22 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPcVlXSEM4ZTE4SF9XUDZxY05Hazhwb2FDcXJhdkpGQlcxWmZHQldTQ0xVS2xQS0haM1IxR1M5cVViYzFlU3ZGR0w5SXY0Y0ZDQ3E4X3daS25IV2h3VXFBdU5yLTk1VE1xQXZabVNRYlFYTG9EbWVSRUt0RWtVSVhCM1d2OA?oc=5" target="_blank"&gt;[크리스탈지노믹스, 주주연대 소송전]②“경영권 방어” vs “임상에 필요한 자금”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스, 신약 '아셀렉스' 원가 낮춘다 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTFBISGd5RndaRDI1WkRialJzbXN0eHhmWmFDbWZNMVh4Q2YwZjhnQmVVRlpxa1o0Q2E1c3IxUkQ1eHlhNEp4T3V2ek9JSUdibVE?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTFBISGd5RndaRDI1WkRialJzbXN0eHhmWmFDbWZNMVh4Q2YwZjhnQmVVRlpxa1o0Q2E1c3IxUkQ1eHlhNEp4T3V2ek9JSUdibVE</guid><pubDate>Tue, 01 Oct 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBISGd5RndaRDI1WkRialJzbXN0eHhmWmFDbWZNMVh4Q2YwZjhnQmVVRlpxa1o0Q2E1c3IxUkQ1eHlhNEp4T3V2ek9JSUdibVE?oc=5" target="_blank"&gt;크리스탈지노믹스, 신약 '아셀렉스' 원가 낮춘다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스 "코로나 치료제 임상2상 조기종료" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5aUDNITk5BcE85ZzJDTldnQzcwUllnZTJ5R0dDRmloaFdhLXd1cmdYRzBoMnMxdEtHQzZUaU8zOXUtc0lFZEc2N3FpZlNmeWM?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5aUDNITk5BcE85ZzJDTldnQzcwUllnZTJ5R0dDRmloaFdhLXd1cmdYRzBoMnMxdEtHQzZUaU8zOXUtc0lFZEc2N3FpZlNmeWM</guid><pubDate>Fri, 01 Jul 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5aUDNITk5BcE85ZzJDTldnQzcwUllnZTJ5R0dDRmloaFdhLXd1cmdYRzBoMnMxdEtHQzZUaU8zOXUtc0lFZEc2N3FpZlNmeWM?oc=5" target="_blank"&gt;크리스탈지노믹스 "코로나 치료제 임상2상 조기종료"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>단독 | 휴온스그룹, 새 가족으로 '크리스탈생명과학' 품는다 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBnZHZiVDk0WkNQbm4xRDJOUHJyUGV5WFo2QS02aFIwd293UW0zTHFIUEtYek9uYzAxc1hXZ1JoZkNJclFoeWp4NlptZ3dDVVhBUjNTZjIzcXdGMTFvdzg5VVp4el9kdkdmdEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBnZHZiVDk0WkNQbm4xRDJOUHJyUGV5WFo2QS02aFIwd293UW0zTHFIUEtYek9uYzAxc1hXZ1JoZkNJclFoeWp4NlptZ3dDVVhBUjNTZjIzcXdGMTFvdzg5VVp4el9kdkdmdEE</guid><pubDate>Wed, 20 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBnZHZiVDk0WkNQbm4xRDJOUHJyUGV5WFo2QS02aFIwd293UW0zTHFIUEtYek9uYzAxc1hXZ1JoZkNJclFoeWp4NlptZ3dDVVhBUjNTZjIzcXdGMTFvdzg5VVp4el9kdkdmdEE?oc=5" target="_blank"&gt;단독 | 휴온스그룹, 새 가족으로 '크리스탈생명과학' 품는다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>크리스탈지노믹스 "췌장암 물질 라이선스 모색" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTFBiRFBhdXVnNUQ2bEp2aHFmNS1tbzVocURMWU9uZ2NKZ0Vaa2NncXFXUDBhbjhhaUQyRkJCQjRiRjI5dFJ6UEFwQUlHbVV5NDQ?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTFBiRFBhdXVnNUQ2bEp2aHFmNS1tbzVocURMWU9uZ2NKZ0Vaa2NncXFXUDBhbjhhaUQyRkJCQjRiRjI5dFJ6UEFwQUlHbVV5NDQ</guid><pubDate>Thu, 22 Dec 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBiRFBhdXVnNUQ2bEp2aHFmNS1tbzVocURMWU9uZ2NKZ0Vaa2NncXFXUDBhbjhhaUQyRkJCQjRiRjI5dFJ6UEFwQUlHbVV5NDQ?oc=5" target="_blank"&gt;크리스탈지노믹스 "췌장암 물질 라이선스 모색"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 정인철·신승수 공동대표 체제 가동 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE92SlZaRFo2ZFllMHlBOVgyb2g3TWxQX2haLVhZNTVuZHJZVXNCWGMyclRMMFFXd0pNVUh2T0ZPOHB5WTJzSEtOQkh4OE1VaWM?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE92SlZaRFo2ZFllMHlBOVgyb2g3TWxQX2haLVhZNTVuZHJZVXNCWGMyclRMMFFXd0pNVUh2T0ZPOHB5WTJzSEtOQkh4OE1VaWM</guid><pubDate>Fri, 14 Apr 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE92SlZaRFo2ZFllMHlBOVgyb2g3TWxQX2haLVhZNTVuZHJZVXNCWGMyclRMMFFXd0pNVUh2T0ZPOHB5WTJzSEtOQkh4OE1VaWM?oc=5" target="_blank"&gt;크리스탈지노믹스, 정인철·신승수 공동대표 체제 가동&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 파이프라인 40개로 확충…임상 속도는 ↑ - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxNeDUxanhpU1pfcm96TEt0REs3SzZxNjBGc3ZUN2RMSkZ4UWJ0dWgySWxBUHNPRzlwcVZxNVdzSDRWVFZlcDh1aEtwMkJzb19RbkJsdkJoeGp2WGhtRk8yeEV4QU9PUmJSQi1FNFVCVF83ajE5emJzaVhYTXk3cnZRNmtiMA?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxNeDUxanhpU1pfcm96TEt0REs3SzZxNjBGc3ZUN2RMSkZ4UWJ0dWgySWxBUHNPRzlwcVZxNVdzSDRWVFZlcDh1aEtwMkJzb19RbkJsdkJoeGp2WGhtRk8yeEV4QU9PUmJSQi1FNFVCVF83ajE5emJzaVhYTXk3cnZRNmtiMA</guid><pubDate>Fri, 02 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNeDUxanhpU1pfcm96TEt0REs3SzZxNjBGc3ZUN2RMSkZ4UWJ0dWgySWxBUHNPRzlwcVZxNVdzSDRWVFZlcDh1aEtwMkJzb19RbkJsdkJoeGp2WGhtRk8yeEV4QU9PUmJSQi1FNFVCVF83ajE5emJzaVhYTXk3cnZRNmtiMA?oc=5" target="_blank"&gt;크리스탈지노믹스, 파이프라인 40개로 확충…임상 속도는 ↑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스, 췌장암 임상 1b/2상 환자 투약 완료 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBicHpSYmhPUmdMaWR4YkFwRDcyT0lpSUpEUWEwelRpbXE2Y2pDV3QtWkRqT3hrTGRBd0lOYnZ1ZFFMU0RCYXR3RnY3RmJ4Ny1McHNkS2cyaUpDMzFMekZGTDJrQUZwQVIyNkZ3S0RB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBicHpSYmhPUmdMaWR4YkFwRDcyT0lpSUpEUWEwelRpbXE2Y2pDV3QtWkRqT3hrTGRBd0lOYnZ1ZFFMU0RCYXR3RnY3RmJ4Ny1McHNkS2cyaUpDMzFMekZGTDJrQUZwQVIyNkZ3S0RB</guid><pubDate>Tue, 06 Dec 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBicHpSYmhPUmdMaWR4YkFwRDcyT0lpSUpEUWEwelRpbXE2Y2pDV3QtWkRqT3hrTGRBd0lOYnZ1ZFFMU0RCYXR3RnY3RmJ4Ny1McHNkS2cyaUpDMzFMekZGTDJrQUZwQVIyNkZ3S0RB?oc=5" target="_blank"&gt;크리스탈지노믹스, 췌장암 임상 1b/2상 환자 투약 완료&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈지노믹스, 면역학회서 '새 관절염 치료법 연구 발표" - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1FOV85VFB4d0RGdHhXRk95Vkw2XzRlNlI0Vi1JM29VN0hFMWFwSnhXNVkyVHVxaU1iajZLaTA5OE1FVjJKNWlHYWI2bEpDcmFCdXFEZmQwQ3MxYnVfaVhRVWRSY0NwOUpnVFlPVVVaUXBqVDg?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1FOV85VFB4d0RGdHhXRk95Vkw2XzRlNlI0Vi1JM29VN0hFMWFwSnhXNVkyVHVxaU1iajZLaTA5OE1FVjJKNWlHYWI2bEpDcmFCdXFEZmQwQ3MxYnVfaVhRVWRSY0NwOUpnVFlPVVVaUXBqVDg</guid><pubDate>Mon, 17 Apr 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1FOV85VFB4d0RGdHhXRk95Vkw2XzRlNlI0Vi1JM29VN0hFMWFwSnhXNVkyVHVxaU1iajZLaTA5OE1FVjJKNWlHYWI2bEpDcmFCdXFEZmQwQ3MxYnVfaVhRVWRSY0NwOUpnVFlPVVVaUXBqVDg?oc=5" target="_blank"&gt;크리스탈지노믹스, 면역학회서 '새 관절염 치료법 연구 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈지노믹스 "파미노젠과 AI 기반 혁신신약 발굴" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5Db2JwRzlqMTVHMjR2NjlfNnBsRVNZVkczN3BwOFlXMVNzUzdoZGlwSkI5aEhFMFVveWtHVk0zZmNIcFQ0YUd4VnZ0bzBHNHc?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5Db2JwRzlqMTVHMjR2NjlfNnBsRVNZVkczN3BwOFlXMVNzUzdoZGlwSkI5aEhFMFVveWtHVk0zZmNIcFQ0YUd4VnZ0bzBHNHc</guid><pubDate>Mon, 28 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5Db2JwRzlqMTVHMjR2NjlfNnBsRVNZVkczN3BwOFlXMVNzUzdoZGlwSkI5aEhFMFVveWtHVk0zZmNIcFQ0YUd4VnZ0bzBHNHc?oc=5" target="_blank"&gt;크리스탈지노믹스 "파미노젠과 AI 기반 혁신신약 발굴"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 러시아 ‘아셀렉스’ 200만 달러 규모 수주 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE45ckVnUUUxQkxkRlcxWUJtTl96blY1OGFYRU9hOEFyaG5TV2g3cUFOOVZqY05tMnlRd3lLMHBtdkZKNFpSZGJjMEpoMTJCeXZCalVwYTV1Tk1YOFd2VnJ4R1ExMG9sVmlXTndfRlh3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE45ckVnUUUxQkxkRlcxWUJtTl96blY1OGFYRU9hOEFyaG5TV2g3cUFOOVZqY05tMnlRd3lLMHBtdkZKNFpSZGJjMEpoMTJCeXZCalVwYTV1Tk1YOFd2VnJ4R1ExMG9sVmlXTndfRlh3</guid><pubDate>Wed, 07 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE45ckVnUUUxQkxkRlcxWUJtTl96blY1OGFYRU9hOEFyaG5TV2g3cUFOOVZqY05tMnlRd3lLMHBtdkZKNFpSZGJjMEpoMTJCeXZCalVwYTV1Tk1YOFd2VnJ4R1ExMG9sVmlXTndfRlh3?oc=5" target="_blank"&gt;크리스탈지노믹스, 러시아 ‘아셀렉스’ 200만 달러 규모 수주&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스, ‘아셀렉스’ 건강보험 급여 확대 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5vbTBoN3Q1RG5MbWh3VWpNWU9mTVhta1NobG9zaEUwUW9uMVNTQkNoQnh5V1J4YU92STlPbnoxZWFQNTlWa1dWVU0yQVhtdXJkdXNTSW1qV1h5dEZmdnhVVkw0VGhzWXhNYnc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5vbTBoN3Q1RG5MbWh3VWpNWU9mTVhta1NobG9zaEUwUW9uMVNTQkNoQnh5V1J4YU92STlPbnoxZWFQNTlWa1dWVU0yQVhtdXJkdXNTSW1qV1h5dEZmdnhVVkw0VGhzWXhNYnc</guid><pubDate>Fri, 21 Oct 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5vbTBoN3Q1RG5MbWh3VWpNWU9mTVhta1NobG9zaEUwUW9uMVNTQkNoQnh5V1J4YU92STlPbnoxZWFQNTlWa1dWVU0yQVhtdXJkdXNTSW1qV1h5dEZmdnhVVkw0VGhzWXhNYnc?oc=5" target="_blank"&gt;크리스탈지노믹스, ‘아셀렉스’ 건강보험 급여 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>[의학바이오게시판] 크리스탈지노믹스, 간암치료제 캄렐리주맙 병용요법 국내 3상 승인 外 - 동아사이언스</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE54VS1pLXdLRUtwS0hJSGpxalFiR2dKSlpxbUNVVzZnU0J5Y2FYdmtYY2RQbGNsb2VjVzlla0JoWjc5Tnk2Q3BsUVNOZzVDMUdkYlRaTA?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE54VS1pLXdLRUtwS0hJSGpxalFiR2dKSlpxbUNVVzZnU0J5Y2FYdmtYY2RQbGNsb2VjVzlla0JoWjc5Tnk2Q3BsUVNOZzVDMUdkYlRaTA</guid><pubDate>Tue, 18 Aug 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE54VS1pLXdLRUtwS0hJSGpxalFiR2dKSlpxbUNVVzZnU0J5Y2FYdmtYY2RQbGNsb2VjVzlla0JoWjc5Tnk2Q3BsUVNOZzVDMUdkYlRaTA?oc=5" target="_blank"&gt;[의학바이오게시판] 크리스탈지노믹스, 간암치료제 캄렐리주맙 병용요법 국내 3상 승인 外&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;동아사이언스&lt;/font&gt;</description><source url="https://www.dongascience.com">동아사이언스</source></item><item><title>새주인 맞은 CG인바이츠의 숨가빴던 체질개선 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTFB5UzZTMXdYZEVSNUI1aVB0MVZRRlNsbGlhblZuNklFdENDR2g0Tmw3WktOVWU5ZEZOS2tQc3dUbTJReXh5UFhQUklaUGczVEVYbnY1Z1pJOEhna0Ry?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTFB5UzZTMXdYZEVSNUI1aVB0MVZRRlNsbGlhblZuNklFdENDR2g0Tmw3WktOVWU5ZEZOS2tQc3dUbTJReXh5UFhQUklaUGczVEVYbnY1Z1pJOEhna0Ry</guid><pubDate>Wed, 02 Aug 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFB5UzZTMXdYZEVSNUI1aVB0MVZRRlNsbGlhblZuNklFdENDR2g0Tmw3WktOVWU5ZEZOS2tQc3dUbTJReXh5UFhQUklaUGczVEVYbnY1Z1pJOEhna0Ry?oc=5" target="_blank"&gt;새주인 맞은 CG인바이츠의 숨가빴던 체질개선&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>"혈액암 극복" 크리스탈지노믹스 등 국내사들 잰걸음 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMidEFVX3lxTE5LWVIxRlZuSEpfb1JyeDF3YW5JcVBpWnpOaFBKOHFsdk1vdGFfSHh4QUM5WFpmb0Z6QVE0aVlVVGpUcVFlcHdZdWswZS1NX3diSTRjbEJSN0UzYkl3NnlEdWpJcHB0N044NU1ib2QydlF0OGV6?oc=5</link><guid isPermaLink="false">CBMidEFVX3lxTE5LWVIxRlZuSEpfb1JyeDF3YW5JcVBpWnpOaFBKOHFsdk1vdGFfSHh4QUM5WFpmb0Z6QVE0aVlVVGpUcVFlcHdZdWswZS1NX3diSTRjbEJSN0UzYkl3NnlEdWpJcHB0N044NU1ib2QydlF0OGV6</guid><pubDate>Tue, 14 Sep 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5LWVIxRlZuSEpfb1JyeDF3YW5JcVBpWnpOaFBKOHFsdk1vdGFfSHh4QUM5WFpmb0Z6QVE0aVlVVGpUcVFlcHdZdWswZS1NX3diSTRjbEJSN0UzYkl3NnlEdWpJcHB0N044NU1ib2QydlF0OGV6?oc=5" target="_blank"&gt;"혈액암 극복" 크리스탈지노믹스 등 국내사들 잰걸음&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>CG인바이츠로 탈바꿈한 크리스탈지노믹스…"선택과 집중 노린다" - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1MV0R5N0NXSzNRWXNHZjM5anFFaXdlbzlzUEhENFhsd193QS1xUE11UWpkaXlsa0Z3eW9QNzJaQU1UeWV6ZFFKNzBBQmF5cjI5bnpYZDZqc2hrTlgzNjBKdU9RLVhUUDBhQm9n?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1MV0R5N0NXSzNRWXNHZjM5anFFaXdlbzlzUEhENFhsd193QS1xUE11UWpkaXlsa0Z3eW9QNzJaQU1UeWV6ZFFKNzBBQmF5cjI5bnpYZDZqc2hrTlgzNjBKdU9RLVhUUDBhQm9n</guid><pubDate>Fri, 04 Aug 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1MV0R5N0NXSzNRWXNHZjM5anFFaXdlbzlzUEhENFhsd193QS1xUE11UWpkaXlsa0Z3eW9QNzJaQU1UeWV6ZFFKNzBBQmF5cjI5bnpYZDZqc2hrTlgzNjBKdU9RLVhUUDBhQm9n?oc=5" target="_blank"&gt;CG인바이츠로 탈바꿈한 크리스탈지노믹스…"선택과 집중 노린다"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>휴온스, CG인바이츠와 상부상조...잇단 지분 거래 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE5ZXzFsNWpIRldFblNsVl9pTG82dWxnVVlydTlPbmxmNFVwa0c5c1M0UUQ1dGJtaGpRX3Y5dDQxay1aOVhfZ29Uc0w4YXZGb0U4b1NpRFpVS3FZU2lJ?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE5ZXzFsNWpIRldFblNsVl9pTG82dWxnVVlydTlPbmxmNFVwa0c5c1M0UUQ1dGJtaGpRX3Y5dDQxay1aOVhfZ29Uc0w4YXZGb0U4b1NpRFpVS3FZU2lJ</guid><pubDate>Mon, 11 Nov 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5ZXzFsNWpIRldFblNsVl9pTG82dWxnVVlydTlPbmxmNFVwa0c5c1M0UUQ1dGJtaGpRX3Y5dDQxay1aOVhfZ29Uc0w4YXZGb0U4b1NpRFpVS3FZU2lJ?oc=5" target="_blank"&gt;휴온스, CG인바이츠와 상부상조...잇단 지분 거래&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스가 보유한 바이오 기술은? - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBiYlVKa2xJUmhwbEVaTnYyOV9kM0pzV0U4cXptUmVCVkNUaG9DRVg2bEdTY3dpMUhyU0ViVWRKZHEtbmxfLTRWbmxHVXIyNDVrWUV6MkFhMDd0d0ZtekVVSnZrMFBxNGNFUlE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBiYlVKa2xJUmhwbEVaTnYyOV9kM0pzV0U4cXptUmVCVkNUaG9DRVg2bEdTY3dpMUhyU0ViVWRKZHEtbmxfLTRWbmxHVXIyNDVrWUV6MkFhMDd0d0ZtekVVSnZrMFBxNGNFUlE</guid><pubDate>Mon, 20 Nov 2017 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBiYlVKa2xJUmhwbEVaTnYyOV9kM0pzV0U4cXptUmVCVkNUaG9DRVg2bEdTY3dpMUhyU0ViVWRKZHEtbmxfLTRWbmxHVXIyNDVrWUV6MkFhMDd0d0ZtekVVSnZrMFBxNGNFUlE?oc=5" target="_blank"&gt;크리스탈지노믹스가 보유한 바이오 기술은?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 바이오 상장사 품고 '아셀렉스' 설움 털까 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiS0FVX3lxTE5OSmJWRTNtTGZrR3NlU0RCUU4tcTJSTjFkQmRnN3NxSXJUSmtsRmVtWGliYkxKd096WXlTNmV4b1RqZkxLaFBWZTc5QQ?oc=5</link><guid isPermaLink="false">CBMiS0FVX3lxTE5OSmJWRTNtTGZrR3NlU0RCUU4tcTJSTjFkQmRnN3NxSXJUSmtsRmVtWGliYkxKd096WXlTNmV4b1RqZkxLaFBWZTc5QQ</guid><pubDate>Thu, 24 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiS0FVX3lxTE5OSmJWRTNtTGZrR3NlU0RCUU4tcTJSTjFkQmRnN3NxSXJUSmtsRmVtWGliYkxKd096WXlTNmV4b1RqZkxLaFBWZTc5QQ?oc=5" target="_blank"&gt;크리스탈지노믹스, 바이오 상장사 품고 '아셀렉스' 설움 털까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>크리스탈지노믹스, ‘팬젠’ 인수…“토탈 바이오 회사로 탈바꿈 할 것” - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1UaUtRa1RIUS1ybC1qLWJVNFNlZFBuS1RUWGV4eE5zQ3V5b1pUN1dTVnpja3VkUFZfd3lZNF9GSFBQaFhBMDFZN29UOXhTdDVKeE1JZEpqZ19oS08zZVlhZlJleGJ5RFJ1Y2Z6ZnVR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1UaUtRa1RIUS1ybC1qLWJVNFNlZFBuS1RUWGV4eE5zQ3V5b1pUN1dTVnpja3VkUFZfd3lZNF9GSFBQaFhBMDFZN29UOXhTdDVKeE1JZEpqZ19oS08zZVlhZlJleGJ5RFJ1Y2Z6ZnVR</guid><pubDate>Tue, 22 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1UaUtRa1RIUS1ybC1qLWJVNFNlZFBuS1RUWGV4eE5zQ3V5b1pUN1dTVnpja3VkUFZfd3lZNF9GSFBQaFhBMDFZN29UOXhTdDVKeE1JZEpqZ19oS08zZVlhZlJleGJ5RFJ1Y2Z6ZnVR?oc=5" target="_blank"&gt;크리스탈지노믹스, ‘팬젠’ 인수…“토탈 바이오 회사로 탈바꿈 할 것”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>파미노젠, 크리스탈지노믹스와 'AI 신약발굴' 파트너십 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE5kNHl2bHdoZDc0OWZEVk9LbTJ5TWl4QnB6YUQtcVc1WDZKbXBuejFCN0Y4cElHRklEUFFMRkVJTTJzdzJVcnFRQnl1aG5kVm9iXzFLRXgtNA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE5kNHl2bHdoZDc0OWZEVk9LbTJ5TWl4QnB6YUQtcVc1WDZKbXBuejFCN0Y4cElHRklEUFFMRkVJTTJzdzJVcnFRQnl1aG5kVm9iXzFLRXgtNA</guid><pubDate>Mon, 28 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5kNHl2bHdoZDc0OWZEVk9LbTJ5TWl4QnB6YUQtcVc1WDZKbXBuejFCN0Y4cElHRklEUFFMRkVJTTJzdzJVcnFRQnl1aG5kVm9iXzFLRXgtNA?oc=5" target="_blank"&gt;파미노젠, 크리스탈지노믹스와 'AI 신약발굴' 파트너십&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>크리스탈지노믹스,6월 주주대상 유상증자-전략 방향 설명회 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5mQWpYbnhXeS1DdHBuYm5rT3hCNlhsM2VsSmVoZGctZEQ3X1g3WUhST3d3YkJpVkZSVUViTGZKNnNJNmNPNnQ1M1N3RW9NcGo2RmJfMFpNQmVsNmxhSVItMEtQM2VJbExUMlYwZQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5mQWpYbnhXeS1DdHBuYm5rT3hCNlhsM2VsSmVoZGctZEQ3X1g3WUhST3d3YkJpVkZSVUViTGZKNnNJNmNPNnQ1M1N3RW9NcGo2RmJfMFpNQmVsNmxhSVItMEtQM2VJbExUMlYwZQ</guid><pubDate>Mon, 22 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5mQWpYbnhXeS1DdHBuYm5rT3hCNlhsM2VsSmVoZGctZEQ3X1g3WUhST3d3YkJpVkZSVUViTGZKNnNJNmNPNnQ1M1N3RW9NcGo2RmJfMFpNQmVsNmxhSVItMEtQM2VJbExUMlYwZQ?oc=5" target="_blank"&gt;크리스탈지노믹스,6월 주주대상 유상증자-전략 방향 설명회&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>크리스탈지노믹스, ‘아셀렉스’ 처방 확대에도 시장 확대 몰두하는 이유 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFB3eVJRMDVnaURWOGQwa2NBLXJFb1VSNWtBN1NTU0NhUzE4eVB3Y3hHUVI1REtnZWxZSXc0SlpackxGUTg4bXQ1em51TC0xRVBQSjhpS1lVY2gybUgxX3l2M0dFYVlFVk5pakN1ZldsaC1pd9IBdkFVX3lxTE90NVRZTGE5Ty1QbE0wbTFwOHdaZ3VoUGVlTVo1RGl2Z3BFdnJIV3hINVpEck1sUTJzOU1jaF85VnZkZklGWV9yTVVjbjRTT0gyUDVBLXNTVjBSYkFvT3NFcEdWOG1nVXo0SGlGSnIwNmxiaGNIdmc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFB3eVJRMDVnaURWOGQwa2NBLXJFb1VSNWtBN1NTU0NhUzE4eVB3Y3hHUVI1REtnZWxZSXc0SlpackxGUTg4bXQ1em51TC0xRVBQSjhpS1lVY2gybUgxX3l2M0dFYVlFVk5pakN1ZldsaC1pd9IBdkFVX3lxTE90NVRZTGE5Ty1QbE0wbTFwOHdaZ3VoUGVlTVo1RGl2Z3BFdnJIV3hINVpEck1sUTJzOU1jaF85VnZkZklGWV9yTVVjbjRTT0gyUDVBLXNTVjBSYkFvT3NFcEdWOG1nVXo0SGlGSnIwNmxiaGNIdmc</guid><pubDate>Fri, 21 Oct 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFB3eVJRMDVnaURWOGQwa2NBLXJFb1VSNWtBN1NTU0NhUzE4eVB3Y3hHUVI1REtnZWxZSXc0SlpackxGUTg4bXQ1em51TC0xRVBQSjhpS1lVY2gybUgxX3l2M0dFYVlFVk5pakN1ZldsaC1pd9IBdkFVX3lxTE90NVRZTGE5Ty1QbE0wbTFwOHdaZ3VoUGVlTVo1RGl2Z3BFdnJIV3hINVpEck1sUTJzOU1jaF85VnZkZklGWV9yTVVjbjRTT0gyUDVBLXNTVjBSYkFvT3NFcEdWOG1nVXo0SGlGSnIwNmxiaGNIdmc?oc=5" target="_blank"&gt;크리스탈지노믹스, ‘아셀렉스’ 처방 확대에도 시장 확대 몰두하는 이유&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>크리스탈지노믹스, '코로나19' 국내 2상 “IND 철회” - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE5LMDVJY05FS2Zjd2FrUFpEWEdpbGNrbnZVTjZjN0J5ckhBN0lMb25OTUllTVpQY2lrMTBwOGxsUDR1QkMwQXRLYTdJYXBtQjdLUmN0dll6MA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE5LMDVJY05FS2Zjd2FrUFpEWEdpbGNrbnZVTjZjN0J5ckhBN0lMb25OTUllTVpQY2lrMTBwOGxsUDR1QkMwQXRLYTdJYXBtQjdLUmN0dll6MA</guid><pubDate>Wed, 23 Mar 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5LMDVJY05FS2Zjd2FrUFpEWEdpbGNrbnZVTjZjN0J5ckhBN0lMb25OTUllTVpQY2lrMTBwOGxsUDR1QkMwQXRLYTdJYXBtQjdLUmN0dll6MA?oc=5" target="_blank"&gt;크리스탈지노믹스, '코로나19' 국내 2상 “IND 철회”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>관절염 신약 벤처사 '크리스탈지노믹스' 130억 수주 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9CckFXU05YbTZMR0JGNFlUUG9mTEotb1p2T3BCZU5fdHhmaEtXS1BWVGV6ZXFpRFE2QllQVnBSbE5vc3pJSXg3R0NpV1RoYzB4Umtwa0dKc2hqNnpsaDAzWDN5Sk96S2tTMUhPVk5IR2ZsVVE?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9CckFXU05YbTZMR0JGNFlUUG9mTEotb1p2T3BCZU5fdHhmaEtXS1BWVGV6ZXFpRFE2QllQVnBSbE5vc3pJSXg3R0NpV1RoYzB4Umtwa0dKc2hqNnpsaDAzWDN5Sk96S2tTMUhPVk5IR2ZsVVE</guid><pubDate>Mon, 02 May 2022 11:08:27 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9CckFXU05YbTZMR0JGNFlUUG9mTEotb1p2T3BCZU5fdHhmaEtXS1BWVGV6ZXFpRFE2QllQVnBSbE5vc3pJSXg3R0NpV1RoYzB4Umtwa0dKc2hqNnpsaDAzWDN5Sk96S2tTMUhPVk5IR2ZsVVE?oc=5" target="_blank"&gt;관절염 신약 벤처사 '크리스탈지노믹스' 130억 수주&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBtbEJGMGpPVHlERVMtN0FCT2hubVptR25MUTBUQ0FDZllLSThuQ0g4YWRaa05XTDZ0T0ExQkpXbmEzSmpqSjAtMllfUlo5OHBuaTVoc3RoUmhNQmxWU0hrN1o5QWYtYTdpRXRRQzN3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBtbEJGMGpPVHlERVMtN0FCT2hubVptR25MUTBUQ0FDZllLSThuQ0g4YWRaa05XTDZ0T0ExQkpXbmEzSmpqSjAtMllfUlo5OHBuaTVoc3RoUmhNQmxWU0hrN1o5QWYtYTdpRXRRQzN3</guid><pubDate>Wed, 03 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBtbEJGMGpPVHlERVMtN0FCT2hubVptR25MUTBUQ0FDZllLSThuQ0g4YWRaa05XTDZ0T0ExQkpXbmEzSmpqSjAtMllfUlo5OHBuaTVoc3RoUmhNQmxWU0hrN1o5QWYtYTdpRXRRQzN3?oc=5" target="_blank"&gt;크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스, 美 췌장암 임상 첫 환자 투여 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE83bk96LW5ac3FDcDkwaXd0M2lwdEFSaG9adTBBcEQ4YjRPTEg5ckNfYXcxWE5tQWg5ZnNraV9rcGk3dVRreDltWUE3TVB2LXJqWWpYMA?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE83bk96LW5ac3FDcDkwaXd0M2lwdEFSaG9adTBBcEQ4YjRPTEg5ckNfYXcxWE5tQWg5ZnNraV9rcGk3dVRreDltWUE3TVB2LXJqWWpYMA</guid><pubDate>Wed, 17 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE83bk96LW5ac3FDcDkwaXd0M2lwdEFSaG9adTBBcEQ4YjRPTEg5ckNfYXcxWE5tQWg5ZnNraV9rcGk3dVRreDltWUE3TVB2LXJqWWpYMA?oc=5" target="_blank"&gt;크리스탈지노믹스, 美 췌장암 임상 첫 환자 투여&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 미국서 경구 코로나치료제 1차 독성시험 '이상반응 없음' - 약업신문</title><link>https://news.google.com/rss/articles/CBMifkFVX3lxTFBJWHFyVGVNR3piVjhRaUhLWFdCTHpyNl9zYkJ3RmticWpvMzRoOEFzWVpnb3F5bklqNFBZdVBTRzNlZ2lGYzZlTDY1bUdPMUt5MENBaXVZTnljODRKeDJYRVhzZjRBWWhxTWJIOTRDMjJOWXZCclhPMDZWX2ZnZw?oc=5</link><guid isPermaLink="false">CBMifkFVX3lxTFBJWHFyVGVNR3piVjhRaUhLWFdCTHpyNl9zYkJ3RmticWpvMzRoOEFzWVpnb3F5bklqNFBZdVBTRzNlZ2lGYzZlTDY1bUdPMUt5MENBaXVZTnljODRKeDJYRVhzZjRBWWhxTWJIOTRDMjJOWXZCclhPMDZWX2ZnZw</guid><pubDate>Wed, 14 Jun 2023 04:01:03 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMifkFVX3lxTFBJWHFyVGVNR3piVjhRaUhLWFdCTHpyNl9zYkJ3RmticWpvMzRoOEFzWVpnb3F5bklqNFBZdVBTRzNlZ2lGYzZlTDY1bUdPMUt5MENBaXVZTnljODRKeDJYRVhzZjRBWWhxTWJIOTRDMjJOWXZCclhPMDZWX2ZnZw?oc=5" target="_blank"&gt;크리스탈지노믹스, 미국서 경구 코로나치료제 1차 독성시험 '이상반응 없음'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>크리스탈-휴온스-화일, 한지붕 세가족 경영 스타트 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE9SMVhSZ25QSTJ5NUFkdVQxV2Y2VFRfWWZ4b2pLQmtBSUplZlFZRFVwakNFVHUwMWZCWHYzSDd6OVdOSUdscUk1dWR5S1JqU0FVUHNhWTRfcjYzRU5u?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE9SMVhSZ25QSTJ5NUFkdVQxV2Y2VFRfWWZ4b2pLQmtBSUplZlFZRFVwakNFVHUwMWZCWHYzSDd6OVdOSUdscUk1dWR5S1JqU0FVUHNhWTRfcjYzRU5u</guid><pubDate>Thu, 12 Jan 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9SMVhSZ25QSTJ5NUFkdVQxV2Y2VFRfWWZ4b2pLQmtBSUplZlFZRFVwakNFVHUwMWZCWHYzSDd6OVdOSUdscUk1dWR5S1JqU0FVUHNhWTRfcjYzRU5u?oc=5" target="_blank"&gt;크리스탈-휴온스-화일, 한지붕 세가족 경영 스타트&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>CG인바이츠의 ‘새 판 짜기’…팬젠·화일약품 지분도 판다 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxQbF9FZC1OMzNRRWk0RTRxNk0yY05LQ3I1ZUVqTDlXMmh3ZjNiMHhjR0Q3SWFyOHR5a3RwYnRiZ3VDa0lLVXV1OURHMHJJM0JucXZNd2lNV0NwdHVQQlB4OE05NF9uVUVJeW9qYk14d3JhR2xtSkFnMWtyZjBjYm5RcUtHRQ?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxQbF9FZC1OMzNRRWk0RTRxNk0yY05LQ3I1ZUVqTDlXMmh3ZjNiMHhjR0Q3SWFyOHR5a3RwYnRiZ3VDa0lLVXV1OURHMHJJM0JucXZNd2lNV0NwdHVQQlB4OE05NF9uVUVJeW9qYk14d3JhR2xtSkFnMWtyZjBjYm5RcUtHRQ</guid><pubDate>Thu, 18 Jan 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQbF9FZC1OMzNRRWk0RTRxNk0yY05LQ3I1ZUVqTDlXMmh3ZjNiMHhjR0Q3SWFyOHR5a3RwYnRiZ3VDa0lLVXV1OURHMHJJM0JucXZNd2lNV0NwdHVQQlB4OE05NF9uVUVJeW9qYk14d3JhR2xtSkFnMWtyZjBjYm5RcUtHRQ?oc=5" target="_blank"&gt;CG인바이츠의 ‘새 판 짜기’…팬젠·화일약품 지분도 판다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>[기자의 눈] 크리스탈의 팬젠 인수 승부수 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5NaFFXOTdJT1V1clVBak44aG5lVTJES1lMR25fZ1VmZUdMSk5vUlhkeUZlbHgtOEI4YnkzeFRrWk1tbm5IMk5qMFhXVXRMSHM?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5NaFFXOTdJT1V1clVBak44aG5lVTJES1lMR25fZ1VmZUdMSk5vUlhkeUZlbHgtOEI4YnkzeFRrWk1tbm5IMk5qMFhXVXRMSHM</guid><pubDate>Thu, 24 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5NaFFXOTdJT1V1clVBak44aG5lVTJES1lMR25fZ1VmZUdMSk5vUlhkeUZlbHgtOEI4YnkzeFRrWk1tbm5IMk5qMFhXVXRMSHM?oc=5" target="_blank"&gt;[기자의 눈] 크리스탈의 팬젠 인수 승부수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>코로나19藥 리스크 덜어낸 크리스탈지노믹스, 췌장암 신약개발로 성장 돌파구 찾는다 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE5BSW9uazF0Z1dhakZFVzNxbDY1bVpNRjVRR1QyWDg4R2czV2ZfQ1ZWM0pmYVNhVXZ2NnlzQmxWV00zM3hoQS1QOFZrMnRfdVJva29adE9BNnVrLWcyS3BKZVNqam9wVXdycTd5MG1MdzNiUdIBdkFVX3lxTE8ycHdTWkR5UXk2OHRoUGJnUk54REZhTVRPTU8yclhUcWU5ZHJFaGhaZ3BDbjJwSzBrX251Q1hZMVp3ZFZzajRqOUxPUHI5X0hWTjA4RE11M1gwYmVkU1hJSDBWRnQ5cGVTckRvZ2pyUjM4R2FmdGc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE5BSW9uazF0Z1dhakZFVzNxbDY1bVpNRjVRR1QyWDg4R2czV2ZfQ1ZWM0pmYVNhVXZ2NnlzQmxWV00zM3hoQS1QOFZrMnRfdVJva29adE9BNnVrLWcyS3BKZVNqam9wVXdycTd5MG1MdzNiUdIBdkFVX3lxTE8ycHdTWkR5UXk2OHRoUGJnUk54REZhTVRPTU8yclhUcWU5ZHJFaGhaZ3BDbjJwSzBrX251Q1hZMVp3ZFZzajRqOUxPUHI5X0hWTjA4RE11M1gwYmVkU1hJSDBWRnQ5cGVTckRvZ2pyUjM4R2FmdGc</guid><pubDate>Sat, 20 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5BSW9uazF0Z1dhakZFVzNxbDY1bVpNRjVRR1QyWDg4R2czV2ZfQ1ZWM0pmYVNhVXZ2NnlzQmxWV00zM3hoQS1QOFZrMnRfdVJva29adE9BNnVrLWcyS3BKZVNqam9wVXdycTd5MG1MdzNiUdIBdkFVX3lxTE8ycHdTWkR5UXk2OHRoUGJnUk54REZhTVRPTU8yclhUcWU5ZHJFaGhaZ3BDbjJwSzBrX251Q1hZMVp3ZFZzajRqOUxPUHI5X0hWTjA4RE11M1gwYmVkU1hJSDBWRnQ5cGVTckRvZ2pyUjM4R2FmdGc?oc=5" target="_blank"&gt;코로나19藥 리스크 덜어낸 크리스탈지노믹스, 췌장암 신약개발로 성장 돌파구 찾는다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>크리스탈바이오사이언스, 스팩 ‘밸류언스머저’ 미국 나스닥 상장 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5pdzY2T1FOd2RGd3VZQlpzRWgydU9neEMzclllTWF2emp4MFpDOFdxeGpjLWhvVUJ5VmtnU3ZEUy1pM0hLWS1BRzFCdERjYzNMdkF1QWF4QTh5Z2VOVjJwa2RfRGZFN2U3dHN0YQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5pdzY2T1FOd2RGd3VZQlpzRWgydU9neEMzclllTWF2emp4MFpDOFdxeGpjLWhvVUJ5VmtnU3ZEUy1pM0hLWS1BRzFCdERjYzNMdkF1QWF4QTh5Z2VOVjJwa2RfRGZFN2U3dHN0YQ</guid><pubDate>Fri, 04 Mar 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5pdzY2T1FOd2RGd3VZQlpzRWgydU9neEMzclllTWF2emp4MFpDOFdxeGpjLWhvVUJ5VmtnU3ZEUy1pM0hLWS1BRzFCdERjYzNMdkF1QWF4QTh5Z2VOVjJwa2RfRGZFN2U3dHN0YQ?oc=5" target="_blank"&gt;크리스탈바이오사이언스, 스팩 ‘밸류언스머저’ 미국 나스닥 상장&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>크리스탈지노믹스 ‘캄렐리주맙’ 가교임상 IND 승인 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTFBMbDJ4RzZYWFhIU25UNDBaOXFHVVRxSmExYllPYkh6T0ZwaTkyaXZYSVdYQktycXJQUkUtRG1xdjJKQnRDVWRnOUVRbDZ1RG1sR3FyTER1RUFHM25EYlduZ3JYbWh6T0daRDI2Y0dyRdIBc0FVX3lxTE9EMjZSZndEMW5wY2pXS2czMld4elVOMGpwNDM3V3VpVVhyOU1rWG5XTGZXOENyTklmNmttWGprcXdHWG90OHRKdk95T2xWQWZ6UjhmZktNQXkzdGxyZFpLTU5iWW0yQWthR0pJNG82Nl9sSUk?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTFBMbDJ4RzZYWFhIU25UNDBaOXFHVVRxSmExYllPYkh6T0ZwaTkyaXZYSVdYQktycXJQUkUtRG1xdjJKQnRDVWRnOUVRbDZ1RG1sR3FyTER1RUFHM25EYlduZ3JYbWh6T0daRDI2Y0dyRdIBc0FVX3lxTE9EMjZSZndEMW5wY2pXS2czMld4elVOMGpwNDM3V3VpVVhyOU1rWG5XTGZXOENyTklmNmttWGprcXdHWG90OHRKdk95T2xWQWZ6UjhmZktNQXkzdGxyZFpLTU5iWW0yQWthR0pJNG82Nl9sSUk</guid><pubDate>Tue, 21 Feb 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBMbDJ4RzZYWFhIU25UNDBaOXFHVVRxSmExYllPYkh6T0ZwaTkyaXZYSVdYQktycXJQUkUtRG1xdjJKQnRDVWRnOUVRbDZ1RG1sR3FyTER1RUFHM25EYlduZ3JYbWh6T0daRDI2Y0dyRdIBc0FVX3lxTE9EMjZSZndEMW5wY2pXS2czMld4elVOMGpwNDM3V3VpVVhyOU1rWG5XTGZXOENyTklmNmttWGprcXdHWG90OHRKdk95T2xWQWZ6UjhmZktNQXkzdGxyZFpLTU5iWW0yQWthR0pJNG82Nl9sSUk?oc=5" target="_blank"&gt;크리스탈지노믹스 ‘캄렐리주맙’ 가교임상 IND 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>릴리 ‘젬자’ 넘어설 췌장암 신약 개발사는?...크리스탈지노믹스 주목 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBCMmkwMmN2NWMtX0ZrZVdtZVR2aDAxLTdaZkoxT0tnUy1wdWhUS3ZtMng3OGFnSTNwRVQ5UHc0RVk5TlNhd3ZENGVvLVFKUExfSm9jSFFIYl95SjdQcW0tRmp1S2ZVcm9PM2c0bDRn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBCMmkwMmN2NWMtX0ZrZVdtZVR2aDAxLTdaZkoxT0tnUy1wdWhUS3ZtMng3OGFnSTNwRVQ5UHc0RVk5TlNhd3ZENGVvLVFKUExfSm9jSFFIYl95SjdQcW0tRmp1S2ZVcm9PM2c0bDRn</guid><pubDate>Tue, 10 Jan 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBCMmkwMmN2NWMtX0ZrZVdtZVR2aDAxLTdaZkoxT0tnUy1wdWhUS3ZtMng3OGFnSTNwRVQ5UHc0RVk5TlNhd3ZENGVvLVFKUExfSm9jSFFIYl95SjdQcW0tRmp1S2ZVcm9PM2c0bDRn?oc=5" target="_blank"&gt;릴리 ‘젬자’ 넘어설 췌장암 신약 개발사는?...크리스탈지노믹스 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈지노믹스 "7월 美 췌장암 1b상 완료" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTFBXS3VmRUNPYXhjbmhuLUw3VTRTVTM5VGI5cEhZM1piajgtVVVhc2NmMDgtcUMtb1gxSmYwZnBrUFZyQk5vRmxwYS1xbFBqeTA?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTFBXS3VmRUNPYXhjbmhuLUw3VTRTVTM5VGI5cEhZM1piajgtVVVhc2NmMDgtcUMtb1gxSmYwZnBrUFZyQk5vRmxwYS1xbFBqeTA</guid><pubDate>Mon, 12 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBXS3VmRUNPYXhjbmhuLUw3VTRTVTM5VGI5cEhZM1piajgtVVVhc2NmMDgtcUMtb1gxSmYwZnBrUFZyQk5vRmxwYS1xbFBqeTA?oc=5" target="_blank"&gt;크리스탈지노믹스 "7월 美 췌장암 1b상 완료"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5FTERZQUo3Wkx3XzF4dVpmNk1DS3IyNGs4U3JKczFqSEVNS3JQY3dWbzJ4VTVJa2xXa0JGOWtLWHNCNE5ERHRxZ2dBSGtSUnpWTlJvejRPcmIxdm5ITGV4d1g0MUpzODRlbjN2QQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5FTERZQUo3Wkx3XzF4dVpmNk1DS3IyNGs4U3JKczFqSEVNS3JQY3dWbzJ4VTVJa2xXa0JGOWtLWHNCNE5ERHRxZ2dBSGtSUnpWTlJvejRPcmIxdm5ITGV4d1g0MUpzODRlbjN2QQ</guid><pubDate>Wed, 03 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5FTERZQUo3Wkx3XzF4dVpmNk1DS3IyNGs4U3JKczFqSEVNS3JQY3dWbzJ4VTVJa2xXa0JGOWtLWHNCNE5ERHRxZ2dBSGtSUnpWTlJvejRPcmIxdm5ITGV4d1g0MUpzODRlbjN2QQ?oc=5" target="_blank"&gt;크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE9yLUZTSktDU3k3NVZQZmlSTFN2Y1dOLXVsNlllTTFoXzBTZkpkUDdtOFluOFJnM1lZRFk4WG1XNHJCbWJ6UmRtTnAxSVVCRGhUbnFON0dKV1BoNTdHbzdScTl6dGFrdw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE9yLUZTSktDU3k3NVZQZmlSTFN2Y1dOLXVsNlllTTFoXzBTZkpkUDdtOFluOFJnM1lZRFk4WG1XNHJCbWJ6UmRtTnAxSVVCRGhUbnFON0dKV1BoNTdHbzdScTl6dGFrdw</guid><pubDate>Thu, 04 May 2023 02:06:41 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9yLUZTSktDU3k3NVZQZmlSTFN2Y1dOLXVsNlllTTFoXzBTZkpkUDdtOFluOFJnM1lZRFk4WG1XNHJCbWJ6UmRtTnAxSVVCRGhUbnFON0dKV1BoNTdHbzdScTl6dGFrdw?oc=5" target="_blank"&gt;크리스탈지노믹스, 골관절염 신약 ‘폴마콕시브’ 브라질 특허 획득&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>[마켓PRO] 주가 78% 떨어지니 회장님 마음도 변심?…크리스탈지노믹스에 무슨 일? - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5keEp6a0owb19HRnd2SS16bFFEVm9mVDZ6NjFsS1N1dnJSNGw4YmhRZ3BPNHpzWHE2dlFIQzFmOHY5TmNHTnlkS3psaG9uNTNNUk82aW82QVZNQQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5keEp6a0owb19HRnd2SS16bFFEVm9mVDZ6NjFsS1N1dnJSNGw4YmhRZ3BPNHpzWHE2dlFIQzFmOHY5TmNHTnlkS3psaG9uNTNNUk82aW82QVZNQQ</guid><pubDate>Fri, 16 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5keEp6a0owb19HRnd2SS16bFFEVm9mVDZ6NjFsS1N1dnJSNGw4YmhRZ3BPNHpzWHE2dlFIQzFmOHY5TmNHTnlkS3psaG9uNTNNUk82aW82QVZNQQ?oc=5" target="_blank"&gt;[마켓PRO] 주가 78% 떨어지니 회장님 마음도 변심?…크리스탈지노믹스에 무슨 일?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>파미노젠, 크리스탈지노믹스와 'AI 혁신신약 발굴' 공동개발 파트너십 - 약업신문</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTFBwTGpkTTYzTnpCYl9pNW1PM2FzNHBHSjA4ajU0cjNEYklMNVFBemNrTVc0V01ZaUlVY1N3M0VSak9UcFNONDhSTmJNbFVSbWZVQXY5Nml3c3dIOVp6R1B6U0UzRk13eHYwd3RucUlOVQ?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTFBwTGpkTTYzTnpCYl9pNW1PM2FzNHBHSjA4ajU0cjNEYklMNVFBemNrTVc0V01ZaUlVY1N3M0VSak9UcFNONDhSTmJNbFVSbWZVQXY5Nml3c3dIOVp6R1B6U0UzRk13eHYwd3RucUlOVQ</guid><pubDate>Tue, 29 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBwTGpkTTYzTnpCYl9pNW1PM2FzNHBHSjA4ajU0cjNEYklMNVFBemNrTVc0V01ZaUlVY1N3M0VSak9UcFNONDhSTmJNbFVSbWZVQXY5Nml3c3dIOVp6R1B6U0UzRk13eHYwd3RucUlOVQ?oc=5" target="_blank"&gt;파미노젠, 크리스탈지노믹스와 'AI 혁신신약 발굴' 공동개발 파트너십&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>크리스탈지노믹스•다나테인, 골관절염치료 디모드 바이오신약 공동개발 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1qNEpWRHM0ZUMwNXZVNmtnc0hxSjZiX25VdVhpUUZCRjVxdmxYck1mWG5UaTlSUlE1ei0zR3dlV3dJQ0dxT29RWmhjUFhsX2ExN3hGMmwzeGl5bkstakpzRUlnRjlPWF9rMXdVMw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1qNEpWRHM0ZUMwNXZVNmtnc0hxSjZiX25VdVhpUUZCRjVxdmxYck1mWG5UaTlSUlE1ei0zR3dlV3dJQ0dxT29RWmhjUFhsX2ExN3hGMmwzeGl5bkstakpzRUlnRjlPWF9rMXdVMw</guid><pubDate>Thu, 25 Nov 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1qNEpWRHM0ZUMwNXZVNmtnc0hxSjZiX25VdVhpUUZCRjVxdmxYck1mWG5UaTlSUlE1ei0zR3dlV3dJQ0dxT29RWmhjUFhsX2ExN3hGMmwzeGl5bkstakpzRUlnRjlPWF9rMXdVMw?oc=5" target="_blank"&gt;크리스탈지노믹스•다나테인, 골관절염치료 디모드 바이오신약 공동개발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>크리스탈지노믹스·다나테인, 골관절염치료 신약 공동개발 제휴 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxQNTI3VUw1OGgyeXplQzBvUGFNWmZTb3daaXpvUkppX3ltVU56cWZ6dXp4UTIySzVxR21wanAxUlNqaFlpQzFBVlloNDhqYVkyeEFSSlA2NHdlNG03TU5NQTlSYXZhel9vTUxIbHhzWkVPTmJCNFQwYlk3US1vNXRRS0hudw?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxQNTI3VUw1OGgyeXplQzBvUGFNWmZTb3daaXpvUkppX3ltVU56cWZ6dXp4UTIySzVxR21wanAxUlNqaFlpQzFBVlloNDhqYVkyeEFSSlA2NHdlNG03TU5NQTlSYXZhel9vTUxIbHhzWkVPTmJCNFQwYlk3US1vNXRRS0hudw</guid><pubDate>Thu, 25 Nov 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQNTI3VUw1OGgyeXplQzBvUGFNWmZTb3daaXpvUkppX3ltVU56cWZ6dXp4UTIySzVxR21wanAxUlNqaFlpQzFBVlloNDhqYVkyeEFSSlA2NHdlNG03TU5NQTlSYXZhel9vTUxIbHhzWkVPTmJCNFQwYlk3US1vNXRRS0hudw?oc=5" target="_blank"&gt;크리스탈지노믹스·다나테인, 골관절염치료 신약 공동개발 제휴&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>크리스탈, 37억 유상증자… 스위스 바이오텍 '전략적 투자' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9HekdoNWpwQWU2b1RKVnU2eUtFaTJXUWt4T2xoRFJ1Ym9QMFRuLW1NOTc5NGtleHZ0QXI4NGQ4QnVYVFd0TmFIbi0tTXZTeEJ0WEZqTDZWYVAzczlvLTBoWGpJdEdFcHVUWnl3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9HekdoNWpwQWU2b1RKVnU2eUtFaTJXUWt4T2xoRFJ1Ym9QMFRuLW1NOTc5NGtleHZ0QXI4NGQ4QnVYVFd0TmFIbi0tTXZTeEJ0WEZqTDZWYVAzczlvLTBoWGpJdEdFcHVUWnl3</guid><pubDate>Mon, 20 Apr 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9HekdoNWpwQWU2b1RKVnU2eUtFaTJXUWt4T2xoRFJ1Ym9QMFRuLW1NOTc5NGtleHZ0QXI4NGQ4QnVYVFd0TmFIbi0tTXZTeEJ0WEZqTDZWYVAzczlvLTBoWGpJdEdFcHVUWnl3?oc=5" target="_blank"&gt;크리스탈, 37억 유상증자… 스위스 바이오텍 '전략적 투자'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>크리스탈이 인수하는 팬젠, 어떤 매력 갖고 있나 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE5Fdkt1ZF82RGd0ZE4zc2VOWF9xWFZONVh0aHlpaGNpTXJBZEhGODN2a0RGcFE0cnQzcjVQQzktTGFTb2JiVkpYbjlkbUt0Mjh0MGtDMFFqT1UwNWx6?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE5Fdkt1ZF82RGd0ZE4zc2VOWF9xWFZONVh0aHlpaGNpTXJBZEhGODN2a0RGcFE0cnQzcjVQQzktTGFTb2JiVkpYbjlkbUt0Mjh0MGtDMFFqT1UwNWx6</guid><pubDate>Sat, 26 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE5Fdkt1ZF82RGd0ZE4zc2VOWF9xWFZONVh0aHlpaGNpTXJBZEhGODN2a0RGcFE0cnQzcjVQQzktTGFTb2JiVkpYbjlkbUt0Mjh0MGtDMFFqT1UwNWx6?oc=5" target="_blank"&gt;크리스탈이 인수하는 팬젠, 어떤 매력 갖고 있나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스,아이발티노스타트 관련 새 제조방법 미국특허 취득 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5MQXAtWUNNUW9XdlFqMDBQeVJRZXRZTXVsNkh6VUtzTEk2WlQxb25yT0tIaGt5V0t1ZTF5NjlyNVpHU25vM1dDdjdVWmFBMlVmcVZxTHF0dDlvR2FOZTdmY2xhX1NFMkc3NlJsZA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5MQXAtWUNNUW9XdlFqMDBQeVJRZXRZTXVsNkh6VUtzTEk2WlQxb25yT0tIaGt5V0t1ZTF5NjlyNVpHU25vM1dDdjdVWmFBMlVmcVZxTHF0dDlvR2FOZTdmY2xhX1NFMkc3NlJsZA</guid><pubDate>Thu, 08 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5MQXAtWUNNUW9XdlFqMDBQeVJRZXRZTXVsNkh6VUtzTEk2WlQxb25yT0tIaGt5V0t1ZTF5NjlyNVpHU25vM1dDdjdVWmFBMlVmcVZxTHF0dDlvR2FOZTdmY2xhX1NFMkc3NlJsZA?oc=5" target="_blank"&gt;크리스탈지노믹스,아이발티노스타트 관련 새 제조방법 미국특허 취득&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>기대 모으는 크리스탈지노믹스 췌장암 신약 경쟁력은? - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE90SGpicVZnUW00WGFJbl8xQjZtYWU5X1lMaExDR1kwdE1pM3otcS12MGVCU2pTc0NERndmQWhjRk9fSjdUc1EwTXgwMm5iN1UwQUJieXVnYllvVGdIT2tVMWVpUVZ0RVA5bEVDSE10d2FhZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE90SGpicVZnUW00WGFJbl8xQjZtYWU5X1lMaExDR1kwdE1pM3otcS12MGVCU2pTc0NERndmQWhjRk9fSjdUc1EwTXgwMm5iN1UwQUJieXVnYllvVGdIT2tVMWVpUVZ0RVA5bEVDSE10d2FhZw</guid><pubDate>Wed, 16 Jun 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE90SGpicVZnUW00WGFJbl8xQjZtYWU5X1lMaExDR1kwdE1pM3otcS12MGVCU2pTc0NERndmQWhjRk9fSjdUc1EwTXgwMm5iN1UwQUJieXVnYllvVGdIT2tVMWVpUVZ0RVA5bEVDSE10d2FhZw?oc=5" target="_blank"&gt;기대 모으는 크리스탈지노믹스 췌장암 신약 경쟁력은?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>크리스탈지노믹스, 췌장암 신약 개발의 꿈 '난항' - 톱데일리</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE9CTEpLbzZPS3JDRDk2RkxSVVIyRTlFVnduQlFjSTY1Y25MeEY4Y0h3Skk4VDZCMG44VkJhazJrU2Y2VlJhZGV2QmY3cWIyZVk?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE9CTEpLbzZPS3JDRDk2RkxSVVIyRTlFVnduQlFjSTY1Y25MeEY4Y0h3Skk4VDZCMG44VkJhazJrU2Y2VlJhZGV2QmY3cWIyZVk</guid><pubDate>Fri, 04 Mar 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9CTEpLbzZPS3JDRDk2RkxSVVIyRTlFVnduQlFjSTY1Y25MeEY4Y0h3Skk4VDZCMG44VkJhazJrU2Y2VlJhZGV2QmY3cWIyZVk?oc=5" target="_blank"&gt;크리스탈지노믹스, 췌장암 신약 개발의 꿈 '난항'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;톱데일리&lt;/font&gt;</description><source url="https://www.topdaily.kr">톱데일리</source></item><item><title>결국 나온 '아셀렉스' 제네릭, 결국 뿌리는 크리스탈 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFByR2NhN0hISExaelRSbHN3MEtzblNtOU5vMy1yVnc5Ykw4T1FPLUs2NXd4ckpCSWU1Ym5uSnZoM2tjeS1iRUpPZUNjMVVjRnktYm1GN00xRDQ4WmI3SEFQR0Zub29CMVR0Z0xRWA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFByR2NhN0hISExaelRSbHN3MEtzblNtOU5vMy1yVnc5Ykw4T1FPLUs2NXd4ckpCSWU1Ym5uSnZoM2tjeS1iRUpPZUNjMVVjRnktYm1GN00xRDQ4WmI3SEFQR0Zub29CMVR0Z0xRWA</guid><pubDate>Sat, 04 Jun 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFByR2NhN0hISExaelRSbHN3MEtzblNtOU5vMy1yVnc5Ykw4T1FPLUs2NXd4ckpCSWU1Ym5uSnZoM2tjeS1iRUpPZUNjMVVjRnktYm1GN00xRDQ4WmI3SEFQR0Zub29CMVR0Z0xRWA?oc=5" target="_blank"&gt;결국 나온 '아셀렉스' 제네릭, 결국 뿌리는 크리스탈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>크리스탈지노믹스 골관절염 신약 ‘연골재생 효과’ - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBwMTN6TWEzYW5TLTNFeS1IZWEzUTcyalBCTm9Fbnhtc012TERfaklmVW5PU1Z4SlpNd0x3VS15aVZlVFdib3NZUDE2bVRtRkJ6YWUzU184RVFLT0prSjh2RHY2d2VELVVEcEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBwMTN6TWEzYW5TLTNFeS1IZWEzUTcyalBCTm9Fbnhtc012TERfaklmVW5PU1Z4SlpNd0x3VS15aVZlVFdib3NZUDE2bVRtRkJ6YWUzU184RVFLT0prSjh2RHY2d2VELVVEcEE</guid><pubDate>Fri, 17 Dec 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBwMTN6TWEzYW5TLTNFeS1IZWEzUTcyalBCTm9Fbnhtc012TERfaklmVW5PU1Z4SlpNd0x3VS15aVZlVFdib3NZUDE2bVRtRkJ6YWUzU184RVFLT0prSjh2RHY2d2VELVVEcEE?oc=5" target="_blank"&gt;크리스탈지노믹스 골관절염 신약 ‘연골재생 효과’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 면역항암제 '캄렐리주맙' 美 FDA 품목허가신청서 제출 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE8zWWlWeVU0cEhZdmU3SHVQbUcxNFNwbk91ajZnTW9mU1FhN2g3eWxzSlo5SXJ0cC10QmxRay1MSkxETDFNb3AwREVpbUFHZ25GNmdmWm5OTjFPbVdCeU02OFJsVG0tQQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE8zWWlWeVU0cEhZdmU3SHVQbUcxNFNwbk91ajZnTW9mU1FhN2g3eWxzSlo5SXJ0cC10QmxRay1MSkxETDFNb3AwREVpbUFHZ25GNmdmWm5OTjFPbVdCeU02OFJsVG0tQQ</guid><pubDate>Thu, 01 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE8zWWlWeVU0cEhZdmU3SHVQbUcxNFNwbk91ajZnTW9mU1FhN2g3eWxzSlo5SXJ0cC10QmxRay1MSkxETDFNb3AwREVpbUFHZ25GNmdmWm5OTjFPbVdCeU02OFJsVG0tQQ?oc=5" target="_blank"&gt;크리스탈지노믹스, 면역항암제 '캄렐리주맙' 美 FDA 품목허가신청서 제출&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>새주인 맞는 ‘크리스탈지노믹스’ 주가 급등 - 더리포트</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBtNzdDNzltaC0xeEtZdWtacDExRktQNThOaVRkNXROYlM4UWlLdzFqdDRuR0dyY0R0M1QtamJITG9sb0VmMWVRNk8xbjgzUFgzSV94S0FzQm03VkNMM0xPU0Y1eFF4MTNqSXhuVXln?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBtNzdDNzltaC0xeEtZdWtacDExRktQNThOaVRkNXROYlM4UWlLdzFqdDRuR0dyY0R0M1QtamJITG9sb0VmMWVRNk8xbjgzUFgzSV94S0FzQm03VkNMM0xPU0Y1eFF4MTNqSXhuVXln</guid><pubDate>Tue, 23 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBtNzdDNzltaC0xeEtZdWtacDExRktQNThOaVRkNXROYlM4UWlLdzFqdDRuR0dyY0R0M1QtamJITG9sb0VmMWVRNk8xbjgzUFgzSV94S0FzQm03VkNMM0xPU0Y1eFF4MTNqSXhuVXln?oc=5" target="_blank"&gt;새주인 맞는 ‘크리스탈지노믹스’ 주가 급등&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더리포트&lt;/font&gt;</description><source url="https://www.thereport.co.kr">더리포트</source></item><item><title>크리스탈지노믹스, 태국에 '아셀렉스' 227억원 공급 계약 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxQanJVYldjVDNRb3ZodkJ1azc4VnNKWFZEQ1ZVSUZMamdTRE10d3lRTjVLcFdHakhONlpKVXBGa05yMl95Qy1fU0syT2NPTzNjNzVSb19TendwakdpcjZSRVNla1ZmT3p3TUJMaV9qd1dtZHlJb1FqdXR2T1hoRWdtTFVSQQ?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxQanJVYldjVDNRb3ZodkJ1azc4VnNKWFZEQ1ZVSUZMamdTRE10d3lRTjVLcFdHakhONlpKVXBGa05yMl95Qy1fU0syT2NPTzNjNzVSb19TendwakdpcjZSRVNla1ZmT3p3TUJMaV9qd1dtZHlJb1FqdXR2T1hoRWdtTFVSQQ</guid><pubDate>Thu, 09 Sep 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQanJVYldjVDNRb3ZodkJ1azc4VnNKWFZEQ1ZVSUZMamdTRE10d3lRTjVLcFdHakhONlpKVXBGa05yMl95Qy1fU0syT2NPTzNjNzVSb19TendwakdpcjZSRVNla1ZmT3p3TUJMaV9qd1dtZHlJb1FqdXR2T1hoRWdtTFVSQQ?oc=5" target="_blank"&gt;크리스탈지노믹스, 태국에 '아셀렉스' 227억원 공급 계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>[이석준의 시그널] 크리스탈의 유상증자 활용법 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1qdUhhM19zOFB3SW52M0R6ZkNJQmhTQXE1VDVfTHRUSWgwUFh0TmxISXFCX0JCZWlSaE9QMUxJOFNRQUxZZ2RpR0lSOHhCWDg?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1qdUhhM19zOFB3SW52M0R6ZkNJQmhTQXE1VDVfTHRUSWgwUFh0TmxISXFCX0JCZWlSaE9QMUxJOFNRQUxZZ2RpR0lSOHhCWDg</guid><pubDate>Mon, 08 Feb 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1qdUhhM19zOFB3SW52M0R6ZkNJQmhTQXE1VDVfTHRUSWgwUFh0TmxISXFCX0JCZWlSaE9QMUxJOFNRQUxZZ2RpR0lSOHhCWDg?oc=5" target="_blank"&gt;[이석준의 시그널] 크리스탈의 유상증자 활용법&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>크리스탈지노믹스가 가진 신약개발 역량은? - 의학신문</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE15QjdGdjlPUGtIb0w4MU5uNUFSOTh2anRfRnkwRDNyQ0R1ODlyZEVoWHVySnhFMGpKeEVLaWlpT0N3eENLQU5pdlhBdVF1Tm9VWHJYNVVHY09SSmdUQkZMTzA1ZlBsRHhj?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE15QjdGdjlPUGtIb0w4MU5uNUFSOTh2anRfRnkwRDNyQ0R1ODlyZEVoWHVySnhFMGpKeEVLaWlpT0N3eENLQU5pdlhBdVF1Tm9VWHJYNVVHY09SSmdUQkZMTzA1ZlBsRHhj</guid><pubDate>Wed, 28 Sep 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE15QjdGdjlPUGtIb0w4MU5uNUFSOTh2anRfRnkwRDNyQ0R1ODlyZEVoWHVySnhFMGpKeEVLaWlpT0N3eENLQU5pdlhBdVF1Tm9VWHJYNVVHY09SSmdUQkZMTzA1ZlBsRHhj?oc=5" target="_blank"&gt;크리스탈지노믹스가 가진 신약개발 역량은?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 대웅제약과 ‘아셀렉스’ 판매계약 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTFBuNXBRbVpoSkpwTmVLd2hoVURINjJFQTJDcXdUTGhuTzZrSV9FUDRGcGctT0hVb1lyNEN1MGtjTDMtZFE0Z3FhT3VLWlRXaFpEVzJ4cm5R?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTFBuNXBRbVpoSkpwTmVLd2hoVURINjJFQTJDcXdUTGhuTzZrSV9FUDRGcGctT0hVb1lyNEN1MGtjTDMtZFE0Z3FhT3VLWlRXaFpEVzJ4cm5R</guid><pubDate>Tue, 13 Mar 2018 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFBuNXBRbVpoSkpwTmVLd2hoVURINjJFQTJDcXdUTGhuTzZrSV9FUDRGcGctT0hVb1lyNEN1MGtjTDMtZFE0Z3FhT3VLWlRXaFpEVzJ4cm5R?oc=5" target="_blank"&gt;크리스탈지노믹스, 대웅제약과 ‘아셀렉스’ 판매계약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>크리스탈지노믹스 판권 캄렐리주맙, 미FDA 희귀약 지정 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFB5TjZDSU1HcS0zYTNCTzBWbnpyVndMaThKTnBTTUZzTWRYSlhIOTNZWFNkR2stN3ZKeXBzQ1RsLVRGTFR5b3cwOXNPQXBWNF96aTBtZ0NkQ3k2cG1xbU92cEEyZkMwUnM0Q1E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFB5TjZDSU1HcS0zYTNCTzBWbnpyVndMaThKTnBTTUZzTWRYSlhIOTNZWFNkR2stN3ZKeXBzQ1RsLVRGTFR5b3cwOXNPQXBWNF96aTBtZ0NkQ3k2cG1xbU92cEEyZkMwUnM0Q1E</guid><pubDate>Wed, 28 Apr 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFB5TjZDSU1HcS0zYTNCTzBWbnpyVndMaThKTnBTTUZzTWRYSlhIOTNZWFNkR2stN3ZKeXBzQ1RsLVRGTFR5b3cwOXNPQXBWNF96aTBtZ0NkQ3k2cG1xbU92cEEyZkMwUnM0Q1E?oc=5" target="_blank"&gt;크리스탈지노믹스 판권 캄렐리주맙, 미FDA 희귀약 지정&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 신약개발 코스닥 상장사 ‘팬젠’ 인수 - 서울경제TV</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTFB4WFJja3VTUGc4RUtVZWNpTmhqcm93R2cwMEhGTk5ORW5HbHZxZmotQng5Y3RiUzFGYkcyQlNIMGZYZTdjUE01STdCdFB3c1VqZGRoT2RldzE0MWd3SGV3b1VPZW8?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTFB4WFJja3VTUGc4RUtVZWNpTmhqcm93R2cwMEhGTk5ORW5HbHZxZmotQng5Y3RiUzFGYkcyQlNIMGZYZTdjUE01STdCdFB3c1VqZGRoT2RldzE0MWd3SGV3b1VPZW8</guid><pubDate>Tue, 22 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFB4WFJja3VTUGc4RUtVZWNpTmhqcm93R2cwMEhGTk5ORW5HbHZxZmotQng5Y3RiUzFGYkcyQlNIMGZYZTdjUE01STdCdFB3c1VqZGRoT2RldzE0MWd3SGV3b1VPZW8?oc=5" target="_blank"&gt;크리스탈지노믹스, 신약개발 코스닥 상장사 ‘팬젠’ 인수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제TV&lt;/font&gt;</description><source url="https://www.sentv.co.kr">서울경제TV</source></item><item><title>크리스탈, 中 PD-1항체 '캄렐리주맙' 국내 독점권리 확보 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE1IWlB5MG02aFBWV25La3pJb0FXYzY4ZjI3Nk1qN1EwUm1FV2tlcThMUkZEYmlUWDFNaUQ2N1hPQmhYMFNsUy1fUXE2TUJyeDFBbGhhRHN3dw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE1IWlB5MG02aFBWV25La3pJb0FXYzY4ZjI3Nk1qN1EwUm1FV2tlcThMUkZEYmlUWDFNaUQ2N1hPQmhYMFNsUy1fUXE2TUJyeDFBbGhhRHN3dw</guid><pubDate>Tue, 21 Apr 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1IWlB5MG02aFBWV25La3pJb0FXYzY4ZjI3Nk1qN1EwUm1FV2tlcThMUkZEYmlUWDFNaUQ2N1hPQmhYMFNsUy1fUXE2TUJyeDFBbGhhRHN3dw?oc=5" target="_blank"&gt;크리스탈, 中 PD-1항체 '캄렐리주맙' 국내 독점권리 확보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>휴온스, ‘크리스탈생명과학’ 지분 100% 인수 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTFBpWVhmTlNrNldpamhPb3RtYnptZW53X2dRMEpmT3JJVjB1cHpaNGdWd1VicW1uRVRGOHY5cUNtUHZYMnEzcndlWkhvTk1NVlBOMEJVazEzVlNQZUc1SDBBSDFDSWZiVHFhcTNTVHo4Z9IBc0FVX3lxTE80bnlsazFPMUltVjh1Ulk2eGhSd0M3ZlRnVS1FUlFITVR5UFhhRExoWDNSQ0w5dkhIQ1NoMDVsYW5Oa3llNFRJVVhVdEdTU3MwU1NVNUNBZ2R1b3RHTERpUkh2cnZrMmhzdEdXQUxoTDVUa00?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTFBpWVhmTlNrNldpamhPb3RtYnptZW53X2dRMEpmT3JJVjB1cHpaNGdWd1VicW1uRVRGOHY5cUNtUHZYMnEzcndlWkhvTk1NVlBOMEJVazEzVlNQZUc1SDBBSDFDSWZiVHFhcTNTVHo4Z9IBc0FVX3lxTE80bnlsazFPMUltVjh1Ulk2eGhSd0M3ZlRnVS1FUlFITVR5UFhhRExoWDNSQ0w5dkhIQ1NoMDVsYW5Oa3llNFRJVVhVdEdTU3MwU1NVNUNBZ2R1b3RHTERpUkh2cnZrMmhzdEdXQUxoTDVUa00</guid><pubDate>Fri, 22 Dec 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBpWVhmTlNrNldpamhPb3RtYnptZW53X2dRMEpmT3JJVjB1cHpaNGdWd1VicW1uRVRGOHY5cUNtUHZYMnEzcndlWkhvTk1NVlBOMEJVazEzVlNQZUc1SDBBSDFDSWZiVHFhcTNTVHo4Z9IBc0FVX3lxTE80bnlsazFPMUltVjh1Ulk2eGhSd0M3ZlRnVS1FUlFITVR5UFhhRExoWDNSQ0w5dkhIQ1NoMDVsYW5Oa3llNFRJVVhVdEdTU3MwU1NVNUNBZ2R1b3RHTERpUkh2cnZrMmhzdEdXQUxoTDVUa00?oc=5" target="_blank"&gt;휴온스, ‘크리스탈생명과학’ 지분 100% 인수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>크리스탈지노믹스, 고려대와 AI 신약개발 공동연구 - AI타임스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFB0cmhIV3FHRldxLVc0bkIySTlIQ1RZWkJ5ZGpENzdCWG56ZW9sOEdxd0M2QTZaU09KODVtbGtzYWlabEpLVV9GU25hX3JxQWpoMHQ2Y290aWlmbjJjZDAwUnBESWtpbHhVN2c?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFB0cmhIV3FHRldxLVc0bkIySTlIQ1RZWkJ5ZGpENzdCWG56ZW9sOEdxd0M2QTZaU09KODVtbGtzYWlabEpLVV9GU25hX3JxQWpoMHQ2Y290aWlmbjJjZDAwUnBESWtpbHhVN2c</guid><pubDate>Tue, 26 Nov 2019 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFB0cmhIV3FHRldxLVc0bkIySTlIQ1RZWkJ5ZGpENzdCWG56ZW9sOEdxd0M2QTZaU09KODVtbGtzYWlabEpLVV9GU25hX3JxQWpoMHQ2Y290aWlmbjJjZDAwUnBESWtpbHhVN2c?oc=5" target="_blank"&gt;크리스탈지노믹스, 고려대와 AI 신약개발 공동연구&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;AI타임스&lt;/font&gt;</description><source url="https://www.aitimes.com">AI타임스</source></item><item><title>크리스탈지노믹스, 러시아 ‘아셀렉스’ 시판 허가 승인 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE8yNE1rdmFnYS1iWnlNTEhlWUhnWVdvcHAyV0w5dEtoYUEtVDFBQjJ0ZENRUXJ0QzFFN09OWF9sblB5M2VaVnV2OFliaks1ME5oTi04MXEyV2NBQlRibS0tOTFNUmk5ZGlfRkE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE8yNE1rdmFnYS1iWnlNTEhlWUhnWVdvcHAyV0w5dEtoYUEtVDFBQjJ0ZENRUXJ0QzFFN09OWF9sblB5M2VaVnV2OFliaks1ME5oTi04MXEyV2NBQlRibS0tOTFNUmk5ZGlfRkE</guid><pubDate>Thu, 13 Jan 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE8yNE1rdmFnYS1iWnlNTEhlWUhnWVdvcHAyV0w5dEtoYUEtVDFBQjJ0ZENRUXJ0QzFFN09OWF9sblB5M2VaVnV2OFliaks1ME5oTi04MXEyV2NBQlRibS0tOTFNUmk5ZGlfRkE?oc=5" target="_blank"&gt;크리스탈지노믹스, 러시아 ‘아셀렉스’ 시판 허가 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스 캄렐리주맙 중국서 시판 허가 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBJcGJFc2VsY0xWZmxwQ3ltT242TTdDWDJNZFFrS05GLXIxeFd5bUxuSGJfbXQtVFhTRnozQnVLLTJ2MmZjdldYUkhPZXhoNHlidEtidWNmTHA5c1gyR1gxOEdhVjBMd1ZseVM3aVkxRFdCTU0?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBJcGJFc2VsY0xWZmxwQ3ltT242TTdDWDJNZFFrS05GLXIxeFd5bUxuSGJfbXQtVFhTRnozQnVLLTJ2MmZjdldYUkhPZXhoNHlidEtidWNmTHA5c1gyR1gxOEdhVjBMd1ZseVM3aVkxRFdCTU0</guid><pubDate>Sat, 02 Apr 2022 23:32:55 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBJcGJFc2VsY0xWZmxwQ3ltT242TTdDWDJNZFFrS05GLXIxeFd5bUxuSGJfbXQtVFhTRnozQnVLLTJ2MmZjdldYUkhPZXhoNHlidEtidWNmTHA5c1gyR1gxOEdhVjBMd1ZseVM3aVkxRFdCTU0?oc=5" target="_blank"&gt;크리스탈지노믹스 캄렐리주맙 중국서 시판 허가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>화일약품 최대주주, 크리스탈지노믹스 → 다이노나 변경 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBEb0wxZ2lLcTZkM1ZidjVuMEJpTTZscnFJLV9tOE9MRnh1c1otejBmaHBNUHRDQktGdnlYanpVUTRDbDhkTUhoT25OX1JVeS1VMm9VQjQ4OXhMSldld1MycFlLMEZtUS02SXE0?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBEb0wxZ2lLcTZkM1ZidjVuMEJpTTZscnFJLV9tOE9MRnh1c1otejBmaHBNUHRDQktGdnlYanpVUTRDbDhkTUhoT25OX1JVeS1VMm9VQjQ4OXhMSldld1MycFlLMEZtUS02SXE0</guid><pubDate>Sun, 22 Nov 2020 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBEb0wxZ2lLcTZkM1ZidjVuMEJpTTZscnFJLV9tOE9MRnh1c1otejBmaHBNUHRDQktGdnlYanpVUTRDbDhkTUhoT25OX1JVeS1VMm9VQjQ4OXhMSldld1MycFlLMEZtUS02SXE0?oc=5" target="_blank"&gt;화일약품 최대주주, 크리스탈지노믹스 → 다이노나 변경&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>크리스탈지노믹스 "캄렐리주맙, FDA에 간암 허가 신청" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFBGWEJHTFBJRlNXeWxDaU9OZGhVS1pWZms0bmRoVlhyTUVVMEUtRTBBNjRKbHNWb2ViUWFCVlZCLUVKN0ZXQlFFYzVwaVoxSlduc1Rxc1hKeEdlazd3eHZqNA?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFBGWEJHTFBJRlNXeWxDaU9OZGhVS1pWZms0bmRoVlhyTUVVMEUtRTBBNjRKbHNWb2ViUWFCVlZCLUVKN0ZXQlFFYzVwaVoxSlduc1Rxc1hKeEdlazd3eHZqNA</guid><pubDate>Thu, 01 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBGWEJHTFBJRlNXeWxDaU9OZGhVS1pWZms0bmRoVlhyTUVVMEUtRTBBNjRKbHNWb2ViUWFCVlZCLUVKN0ZXQlFFYzVwaVoxSlduc1Rxc1hKeEdlazd3eHZqNA?oc=5" target="_blank"&gt;크리스탈지노믹스 "캄렐리주맙, FDA에 간암 허가 신청"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://oldm.dailypharm.com">데일리팜</source></item><item><title>주인 바뀌는 크리스탈지노믹스…디지털 헬스케어 생태계 합류 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE16Uk1VTXFzM1hEWnNxQk4zSnl1NU85dEpWTjZEWnRGajR1ME5IdTdtNjFfemZKVkwwYjktcHFIdjdReU5PZUEyTlUtdHhPNXJtUHpBVVA2YjBqUdIBVEFVX3lxTFAybE82TDJzUWVXT0lORWV4bjV6eHZtbkxlOHUzQTZDOU9XZ2k2Y2V3TlZzWmhMV0NDSGtKYkk1S2pBM256aWtXcWU4S1NTRzduTWJHaA?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE16Uk1VTXFzM1hEWnNxQk4zSnl1NU85dEpWTjZEWnRGajR1ME5IdTdtNjFfemZKVkwwYjktcHFIdjdReU5PZUEyTlUtdHhPNXJtUHpBVVA2YjBqUdIBVEFVX3lxTFAybE82TDJzUWVXT0lORWV4bjV6eHZtbkxlOHUzQTZDOU9XZ2k2Y2V3TlZzWmhMV0NDSGtKYkk1S2pBM256aWtXcWU4S1NTRzduTWJHaA</guid><pubDate>Mon, 22 May 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE16Uk1VTXFzM1hEWnNxQk4zSnl1NU85dEpWTjZEWnRGajR1ME5IdTdtNjFfemZKVkwwYjktcHFIdjdReU5PZUEyTlUtdHhPNXJtUHpBVVA2YjBqUdIBVEFVX3lxTFAybE82TDJzUWVXT0lORWV4bjV6eHZtbkxlOHUzQTZDOU9XZ2k2Y2V3TlZzWmhMV0NDSGtKYkk1S2pBM256aWtXcWU4S1NTRzduTWJHaA?oc=5" target="_blank"&gt;주인 바뀌는 크리스탈지노믹스…디지털 헬스케어 생태계 합류&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>크리스탈지노믹스 ‘아이발티노스타트’, 델타 변이에 효과 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9YbDVKajBDOUotZDQtZ01PdFZNUk1QN21uTWVOYUJmVmhfZk1fcU9saGQ1RHNuMEcyaFpPcjNtNFdVendwaDAwLWRqWG5sVUxvNmk5aDBnRmJlODFHQlR1bDFOLXRyd0ZSVkE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9YbDVKajBDOUotZDQtZ01PdFZNUk1QN21uTWVOYUJmVmhfZk1fcU9saGQ1RHNuMEcyaFpPcjNtNFdVendwaDAwLWRqWG5sVUxvNmk5aDBnRmJlODFHQlR1bDFOLXRyd0ZSVkE</guid><pubDate>Wed, 01 Dec 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9YbDVKajBDOUotZDQtZ01PdFZNUk1QN21uTWVOYUJmVmhfZk1fcU9saGQ1RHNuMEcyaFpPcjNtNFdVendwaDAwLWRqWG5sVUxvNmk5aDBnRmJlODFHQlR1bDFOLXRyd0ZSVkE?oc=5" target="_blank"&gt;크리스탈지노믹스 ‘아이발티노스타트’, 델타 변이에 효과&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>“한때 떼돈 벌었는데” 다들 부러워했던 신화 주인공…충격 결말 - 헤럴드경제</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE96UGlHT2JWNndWWjRfcjRhTDU3YmowMEtHT2ZVa1NoSW94QzRGOWx3SHY5VlAwTFlqbnltNDVENnJUNVZGNEJfSUFibnhBOG5qc24wbA?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE96UGlHT2JWNndWWjRfcjRhTDU3YmowMEtHT2ZVa1NoSW94QzRGOWx3SHY5VlAwTFlqbnltNDVENnJUNVZGNEJfSUFibnhBOG5qc24wbA</guid><pubDate>Tue, 13 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE96UGlHT2JWNndWWjRfcjRhTDU3YmowMEtHT2ZVa1NoSW94QzRGOWx3SHY5VlAwTFlqbnltNDVENnJUNVZGNEJfSUFibnhBOG5qc24wbA?oc=5" target="_blank"&gt;“한때 떼돈 벌었는데” 다들 부러워했던 신화 주인공…충격 결말&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헤럴드경제&lt;/font&gt;</description><source url="https://biz.heraldcorp.com">헤럴드경제</source></item><item><title>크리스탈지노믹스, 미 FDA 췌장암 임상 2상 승인 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9VX2p3ZGJPMVlMZGp3ci1pN040V0I2bk1ONkRDMXcxYmtDYnF6QU8xdUNFY2M0Vl9qWjhSY2d2UTFwZHI5Z0ZkeHl2SWpUS1R4VFFvVEtRYWxtSWd5VlM3aDBKZFo0UnBJSVE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9VX2p3ZGJPMVlMZGp3ci1pN040V0I2bk1ONkRDMXcxYmtDYnF6QU8xdUNFY2M0Vl9qWjhSY2d2UTFwZHI5Z0ZkeHl2SWpUS1R4VFFvVEtRYWxtSWd5VlM3aDBKZFo0UnBJSVE</guid><pubDate>Mon, 17 Jan 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9VX2p3ZGJPMVlMZGp3ci1pN040V0I2bk1ONkRDMXcxYmtDYnF6QU8xdUNFY2M0Vl9qWjhSY2d2UTFwZHI5Z0ZkeHl2SWpUS1R4VFFvVEtRYWxtSWd5VlM3aDBKZFo0UnBJSVE?oc=5" target="_blank"&gt;크리스탈지노믹스, 미 FDA 췌장암 임상 2상 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 신약개발 전문가 ‘개빈 초이’ 박사 영입 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1ueVNueUkxcnFVRXAxSTZsVE5PUnhqT3YtQzNpbnRjZ0VaTnVIbTlmV3Q5b2hBRS1zeVBPdEYwNDhkSmQ2S3NxNnNNd1Exc0drbXVZVC1wa3UzZ1JwMDc4cS1tUGZQdFZxU0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1ueVNueUkxcnFVRXAxSTZsVE5PUnhqT3YtQzNpbnRjZ0VaTnVIbTlmV3Q5b2hBRS1zeVBPdEYwNDhkSmQ2S3NxNnNNd1Exc0drbXVZVC1wa3UzZ1JwMDc4cS1tUGZQdFZxU0E</guid><pubDate>Thu, 08 Oct 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1ueVNueUkxcnFVRXAxSTZsVE5PUnhqT3YtQzNpbnRjZ0VaTnVIbTlmV3Q5b2hBRS1zeVBPdEYwNDhkSmQ2S3NxNnNNd1Exc0drbXVZVC1wa3UzZ1JwMDc4cS1tUGZQdFZxU0E?oc=5" target="_blank"&gt;크리스탈지노믹스, 신약개발 전문가 ‘개빈 초이’ 박사 영입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, CFO에 경영컨설턴트 정인철 영입 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE5LMUw0Nk5PSXNFUVZzLWh5c2FEZlF6bmxVTFkyb0RiUEdIYWFiQlE5Q1VoNVVWbUFsc3BOMmlmQXN0MWw4cDhERmFwTXNib0hnRGhGRERUTktzZnBFU25DREVlVW9GUFpXbnlnY1NpNXFpQQ?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE5LMUw0Nk5PSXNFUVZzLWh5c2FEZlF6bmxVTFkyb0RiUEdIYWFiQlE5Q1VoNVVWbUFsc3BOMmlmQXN0MWw4cDhERmFwTXNib0hnRGhGRERUTktzZnBFU25DREVlVW9GUFpXbnlnY1NpNXFpQQ</guid><pubDate>Tue, 12 Jan 2016 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5LMUw0Nk5PSXNFUVZzLWh5c2FEZlF6bmxVTFkyb0RiUEdIYWFiQlE5Q1VoNVVWbUFsc3BOMmlmQXN0MWw4cDhERmFwTXNib0hnRGhGRERUTktzZnBFU25DREVlVW9GUFpXbnlnY1NpNXFpQQ?oc=5" target="_blank"&gt;크리스탈지노믹스, CFO에 경영컨설턴트 정인철 영입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>크리스탈지노믹스, 3.93% 오르며 체결강도 강세 지속(154%) - 서울경제</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTFBSaVZUeXVFWVd6UTZPOC1uVDV1QksySmxoSkZZc2NGVlhlcS04SGFpLTV1eHJNOU95cTBtdm9BUVFMTFpOZzZlWjM5UE40MTh0Y2k0?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTFBSaVZUeXVFWVd6UTZPOC1uVDV1QksySmxoSkZZc2NGVlhlcS04SGFpLTV1eHJNOU95cTBtdm9BUVFMTFpOZzZlWjM5UE40MTh0Y2k0</guid><pubDate>Thu, 08 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBSaVZUeXVFWVd6UTZPOC1uVDV1QksySmxoSkZZc2NGVlhlcS04SGFpLTV1eHJNOU95cTBtdm9BUVFMTFpOZzZlWjM5UE40MTh0Y2k0?oc=5" target="_blank"&gt;크리스탈지노믹스, 3.93% 오르며 체결강도 강세 지속(154%)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://m.sedaily.com">서울경제</source></item><item><title>우수 기업연구소에 제일메디칼코퍼레이션·크리스탈지노믹스·휴젤 - 동아사이언스</title><link>https://news.google.com/rss/articles/CBMiTkFVX3lxTE55ZFoxZTdJQlFSTlFHOTBUTHZ5bHNQRnlMcmJlcWFSTTNTemV5U011TkNUSk9GdjBfd0FhRVZFRDhwRWstYlhrRVlKT1JNUQ?oc=5</link><guid isPermaLink="false">CBMiTkFVX3lxTE55ZFoxZTdJQlFSTlFHOTBUTHZ5bHNQRnlMcmJlcWFSTTNTemV5U011TkNUSk9GdjBfd0FhRVZFRDhwRWstYlhrRVlKT1JNUQ</guid><pubDate>Wed, 26 Dec 2018 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTE55ZFoxZTdJQlFSTlFHOTBUTHZ5bHNQRnlMcmJlcWFSTTNTemV5U011TkNUSk9GdjBfd0FhRVZFRDhwRWstYlhrRVlKT1JNUQ?oc=5" target="_blank"&gt;우수 기업연구소에 제일메디칼코퍼레이션·크리스탈지노믹스·휴젤&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;동아사이언스&lt;/font&gt;</description><source url="https://m.dongascience.com">동아사이언스</source></item><item><title>크리스탈지노믹스, 혈액암 치료제 ‘CG-806’ 완전 관해 확인 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBRbl9WR1ZVWEQzR091R1lTRDY2TEVGdDZKemowSHlqdUowWVIxX0thakxPNEYtV3RtcHd1RlQxaWU1WFQ0amNXY29yQ3p0SDM5VzJIOE9WRHVocEltRk8wdm1nNUh3d0hHdFNZUw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBRbl9WR1ZVWEQzR091R1lTRDY2TEVGdDZKemowSHlqdUowWVIxX0thakxPNEYtV3RtcHd1RlQxaWU1WFQ0amNXY29yQ3p0SDM5VzJIOE9WRHVocEltRk8wdm1nNUh3d0hHdFNZUw</guid><pubDate>Wed, 24 Mar 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBRbl9WR1ZVWEQzR091R1lTRDY2TEVGdDZKemowSHlqdUowWVIxX0thakxPNEYtV3RtcHd1RlQxaWU1WFQ0amNXY29yQ3p0SDM5VzJIOE9WRHVocEltRk8wdm1nNUh3d0hHdFNZUw?oc=5" target="_blank"&gt;크리스탈지노믹스, 혈액암 치료제 ‘CG-806’ 완전 관해 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>크리스탈지노믹스 "캄렐리주맙, FDA에 간암 허가 신청" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTE1LV1ZUWUs3RnRKTVU4ajRSSmEwQzBkQjM1a0docS1hM081N0JIc1VLelZtS2JxQ0wzczhlXzBTWS1oZnJhUFRlOTNQVEdpTzF4?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTE1LV1ZUWUs3RnRKTVU4ajRSSmEwQzBkQjM1a0docS1hM081N0JIc1VLelZtS2JxQ0wzczhlXzBTWS1oZnJhUFRlOTNQVEdpTzF4</guid><pubDate>Thu, 01 Jun 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1LV1ZUWUs3RnRKTVU4ajRSSmEwQzBkQjM1a0docS1hM081N0JIc1VLelZtS2JxQ0wzczhlXzBTWS1oZnJhUFRlOTNQVEdpTzF4?oc=5" target="_blank"&gt;크리스탈지노믹스 "캄렐리주맙, FDA에 간암 허가 신청"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://oldm.dailypharm.com">데일리팜</source></item><item><title>크리스탈, 아셀렉스 복합제신약 1상 승인 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE90VXZnTmtrekJtRTdZdk83aEc0VkZrM2NyMmxuYVVES1Z4aXhfSHpHTGk4WUhfMVVzVzN4ZUluVGZPSWVCZXBYNTlpbzh2N0wwMTB4b1pB?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE90VXZnTmtrekJtRTdZdk83aEc0VkZrM2NyMmxuYVVES1Z4aXhfSHpHTGk4WUhfMVVzVzN4ZUluVGZPSWVCZXBYNTlpbzh2N0wwMTB4b1pB</guid><pubDate>Tue, 25 Jun 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE90VXZnTmtrekJtRTdZdk83aEc0VkZrM2NyMmxuYVVES1Z4aXhfSHpHTGk4WUhfMVVzVzN4ZUluVGZPSWVCZXBYNTlpbzh2N0wwMTB4b1pB?oc=5" target="_blank"&gt;크리스탈, 아셀렉스 복합제신약 1상 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>크리스탈지노믹스, ‘팬젠’ 240억원에 인수…"바이오 의약품 확장" - 서울경제</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtN1BqR1k0VVRUWlZVSHRfcENGdmoyN2NUa1ZfVjlFOThmSXJVTDQ4NWkybnR4bXExLXpNczI2ZU1Tb3p1aFdiOE1OSmlqcE0teXNF0gFTQVVfeXFMUG03UGpHWTRVVFRaVlVIdF9wQ0Z2ajI3Y1RrVl9WOUU5OGZJclVMNDg1aTJudHhtcTEtek1zMjZlTVNvenVoV2I4TU5KaWpwTS15c0U?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTFBtN1BqR1k0VVRUWlZVSHRfcENGdmoyN2NUa1ZfVjlFOThmSXJVTDQ4NWkybnR4bXExLXpNczI2ZU1Tb3p1aFdiOE1OSmlqcE0teXNF0gFTQVVfeXFMUG03UGpHWTRVVFRaVlVIdF9wQ0Z2ajI3Y1RrVl9WOUU5OGZJclVMNDg1aTJudHhtcTEtek1zMjZlTVNvenVoV2I4TU5KaWpwTS15c0U</guid><pubDate>Tue, 22 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBtN1BqR1k0VVRUWlZVSHRfcENGdmoyN2NUa1ZfVjlFOThmSXJVTDQ4NWkybnR4bXExLXpNczI2ZU1Tb3p1aFdiOE1OSmlqcE0teXNF0gFTQVVfeXFMUG03UGpHWTRVVFRaVlVIdF9wQ0Z2ajI3Y1RrVl9WOUU5OGZJclVMNDg1aTJudHhtcTEtek1zMjZlTVNvenVoV2I4TU5KaWpwTS15c0U?oc=5" target="_blank"&gt;크리스탈지노믹스, ‘팬젠’ 240억원에 인수…"바이오 의약품 확장"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://m.sedaily.com">서울경제</source></item><item><title>크리스탈지노믹스·항서제약, ‘캄렐리주맙’ 개발범위 확대 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9MRGwxbE85cTQ5SElmTjFyTHpDd0xiTW03V3dtbmExanhwNDUyYmVYdDFQc1RKWTQ0XzIwcTRSRHBkSm44aWxhR25kZUtvR2FhYU9nTmExQ2hmQUx3cU8tMUdVSXZjeW8yb3c?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9MRGwxbE85cTQ5SElmTjFyTHpDd0xiTW03V3dtbmExanhwNDUyYmVYdDFQc1RKWTQ0XzIwcTRSRHBkSm44aWxhR25kZUtvR2FhYU9nTmExQ2hmQUx3cU8tMUdVSXZjeW8yb3c</guid><pubDate>Mon, 30 May 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9MRGwxbE85cTQ5SElmTjFyTHpDd0xiTW03V3dtbmExanhwNDUyYmVYdDFQc1RKWTQ0XzIwcTRSRHBkSm44aWxhR25kZUtvR2FhYU9nTmExQ2hmQUx3cU8tMUdVSXZjeW8yb3c?oc=5" target="_blank"&gt;크리스탈지노믹스·항서제약, ‘캄렐리주맙’ 개발범위 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>크리스탈지노믹스, 췌장암 치료제 임상2상을 미국 식품의약국에 신청 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE9UR0xJemdZb1dHbWJFbVBjMGFnWU1lQnpwVUdJOWgwTTc0SDRrRlFUaEt1ejdVTnY1VWphVFhEbjR5MEt2WWRuZzNUTFNtSGZFMzRDQ1pMZWdIU3NCT0RtMmdYZHlmZ0IwVmxwTXREWjk3bjA?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE9UR0xJemdZb1dHbWJFbVBjMGFnWU1lQnpwVUdJOWgwTTc0SDRrRlFUaEt1ejdVTnY1VWphVFhEbjR5MEt2WWRuZzNUTFNtSGZFMzRDQ1pMZWdIU3NCT0RtMmdYZHlmZ0IwVmxwTXREWjk3bjA</guid><pubDate>Mon, 20 Dec 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9UR0xJemdZb1dHbWJFbVBjMGFnWU1lQnpwVUdJOWgwTTc0SDRrRlFUaEt1ejdVTnY1VWphVFhEbjR5MEt2WWRuZzNUTFNtSGZFMzRDQ1pMZWdIU3NCT0RtMmdYZHlmZ0IwVmxwTXREWjk3bjA?oc=5" target="_blank"&gt;크리스탈지노믹스, 췌장암 치료제 임상2상을 미국 식품의약국에 신청&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>[만나봤더니] 노벨상 이슈 속 크리스탈, 'CG-598' 기술수출 가능성 - 딜사이트</title><link>https://news.google.com/rss/articles/CBMiTkFVX3lxTE1GWWZaZ3RkUzE2QklUNHZfcDJYQ2duT0RqUms5YVhIdmRxRWFhMGhvMWt1THcyR1pwcmNobm9LaXN2elduaVpsYk0ybExsZw?oc=5</link><guid isPermaLink="false">CBMiTkFVX3lxTE1GWWZaZ3RkUzE2QklUNHZfcDJYQ2duT0RqUms5YVhIdmRxRWFhMGhvMWt1THcyR1pwcmNobm9LaXN2elduaVpsYk0ybExsZw</guid><pubDate>Fri, 11 Oct 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTE1GWWZaZ3RkUzE2QklUNHZfcDJYQ2duT0RqUms5YVhIdmRxRWFhMGhvMWt1THcyR1pwcmNobm9LaXN2elduaVpsYk0ybExsZw?oc=5" target="_blank"&gt;[만나봤더니] 노벨상 이슈 속 크리스탈, 'CG-598' 기술수출 가능성&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;딜사이트&lt;/font&gt;</description><source url="https://dealsite.co.kr">딜사이트</source></item><item><title>크리스탈지노믹스, ‘췌장암 임상 2상 연구결과’ 국제학술지 게재 - 약업신문</title><link>https://news.google.com/rss/articles/CBMifkFVX3lxTE1meXFHWVg5Z0pZQmFMSWxrZGZGem0xWHZJVlhHXzVhaWM4Ym8tcjR0MTRXT0lVOVBmZ1FqVThBbl9mTHNPdmFjOEZGZ3l0T2pJbS1WdW9fdWxTdGtUM1dBZWcwYnRub3ZDTnFKN2xPN0JFYW5lY1dvLVlUaUdGdw?oc=5</link><guid isPermaLink="false">CBMifkFVX3lxTE1meXFHWVg5Z0pZQmFMSWxrZGZGem0xWHZJVlhHXzVhaWM4Ym8tcjR0MTRXT0lVOVBmZ1FqVThBbl9mTHNPdmFjOEZGZ3l0T2pJbS1WdW9fdWxTdGtUM1dBZWcwYnRub3ZDTnFKN2xPN0JFYW5lY1dvLVlUaUdGdw</guid><pubDate>Sun, 11 Jun 2023 01:02:36 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1meXFHWVg5Z0pZQmFMSWxrZGZGem0xWHZJVlhHXzVhaWM4Ym8tcjR0MTRXT0lVOVBmZ1FqVThBbl9mTHNPdmFjOEZGZ3l0T2pJbS1WdW9fdWxTdGtUM1dBZWcwYnRub3ZDTnFKN2xPN0JFYW5lY1dvLVlUaUdGdw?oc=5" target="_blank"&gt;크리스탈지노믹스, ‘췌장암 임상 2상 연구결과’ 국제학술지 게재&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>크리스탈지노믹스, 코로나19 치료제 임상을 미국 전문기관에 맡겨 - 비즈니스포스트</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBzeVIxTHBGMXBia01HakJJLTl4VkRUcmxiMFVsRklITHgxVUVMQWo1UDJDeEVTR2FiTEFXYWt0NG1HeG1rd1h0aVpQV2FuUmpObnVzZFk4dFR5OUM2c3R3SnhhdUNJRlpZVUl2S2ZpS3BERzA?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBzeVIxTHBGMXBia01HakJJLTl4VkRUcmxiMFVsRklITHgxVUVMQWo1UDJDeEVTR2FiTEFXYWt0NG1HeG1rd1h0aVpQV2FuUmpObnVzZFk4dFR5OUM2c3R3SnhhdUNJRlpZVUl2S2ZpS3BERzA</guid><pubDate>Fri, 04 Sep 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBzeVIxTHBGMXBia01HakJJLTl4VkRUcmxiMFVsRklITHgxVUVMQWo1UDJDeEVTR2FiTEFXYWt0NG1HeG1rd1h0aVpQV2FuUmpObnVzZFk4dFR5OUM2c3R3SnhhdUNJRlpZVUl2S2ZpS3BERzA?oc=5" target="_blank"&gt;크리스탈지노믹스, 코로나19 치료제 임상을 미국 전문기관에 맡겨&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;비즈니스포스트&lt;/font&gt;</description><source url="https://www.businesspost.co.kr">비즈니스포스트</source></item><item><title>크리스탈지노믹스, 800억 기관 투자 유치 - 서울경제</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3U0I0Zmp6bUxWMGhma1hMMlc4blIwSmxQZ1BQMlU1LV9DLXlLd3hRMnV4V2xMcmdiWEdiWGdZMEFoSV9jMno0enBoSTdHSmZfU0040gFTQVVfeXFMUDdTQjRmanptTFYwaGZrWEwyVzhuUjBKbFBnUFAyVTUtX0MteUt3eFEydXhXbExyZ2JYR2JYZ1kwQWhJX2MyejR6cGhJN0dKZl9TTTg?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTFA3U0I0Zmp6bUxWMGhma1hMMlc4blIwSmxQZ1BQMlU1LV9DLXlLd3hRMnV4V2xMcmdiWEdiWGdZMEFoSV9jMno0enBoSTdHSmZfU0040gFTQVVfeXFMUDdTQjRmanptTFYwaGZrWEwyVzhuUjBKbFBnUFAyVTUtX0MteUt3eFEydXhXbExyZ2JYR2JYZ1kwQWhJX2MyejR6cGhJN0dKZl9TTTg</guid><pubDate>Wed, 31 Oct 2018 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3U0I0Zmp6bUxWMGhma1hMMlc4blIwSmxQZ1BQMlU1LV9DLXlLd3hRMnV4V2xMcmdiWEdiWGdZMEFoSV9jMno0enBoSTdHSmZfU0040gFTQVVfeXFMUDdTQjRmanptTFYwaGZrWEwyVzhuUjBKbFBnUFAyVTUtX0MteUt3eFEydXhXbExyZ2JYR2JYZ1kwQWhJX2MyejR6cGhJN0dKZl9TTTg?oc=5" target="_blank"&gt;크리스탈지노믹스, 800억 기관 투자 유치&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://m.sedaily.com">서울경제</source></item></channel></rss>